Alcam
activated leukocyte cell adhesion molecule
ALCAM; activated leukocyte cell adhesion molecule; MEMD; CD166; CD166 antigen; FLJ3851; FLJ38514; MGC71733;
BAD
BCL2-associated agonist of cell death
BAD; BCL2-associated agonist of cell death; BBC2; BCL2L8; bcl2 antagonist of cell death; bcl2-L-8; BCL2-binding protein; bcl-2-like protein 8; BCL2-binding component 6; bcl-2-binding component 6; BCL-X/BCL-2 binding protein; BCL2-antagonist of cell death protein; bcl-XL/Bcl-2-associated death promoter;
BCAM
basal cell adhesion molecule
BCAM; basal cell adhesion molecule; lutheran antigen; Auberger b antigen; Lutheran blood group; lutheran glycoprotein; B-CAM cell surface glycoprotein; Lu; Gplu; B-CAM; 1200005K12Rik;
BCL6
B-cell CLL/lymphoma 6
BCL6; B-cell CLL/lymphoma 6; BCL5; LAZ3; BCL6A; ZNF51; ZBTB27; B-cell lymphoma 6 protein; BCL-5; BCL-6; protein LAZ-3; zinc finger protein 51; B-cell lymphoma 5 protein; B-cell lymphoma 6 protein transcript; zinc finger transcription factor BCL6S; cys-his2 zinc finger transcription factor; zinc finger and BTB domain-containing protein 27; lymphoma-associated zinc finger gene on chromosome 3;
BLNK
B cell linker
BLNK; B cell linker; B-cell linker protein; lymphocyte antigen 57; cytoplasmic adapter protein; B-cell adapter containing a SH2 domain protein; B-cell adapter containing a Src homology 2 domain protein; src homology 2 domain-containing leukocyte protein of 65 kDa; Bca; BASH; Ly57; Ly-57; Lyw-57; SLP-65;
BST1
bone marrow stromal cell antigen 1
BST1; bone marrow stromal cell antigen 1; ADP-ribosyl cyclase 2; ADP ribosyl cyclase 2; CD157; NAD(+) nucleosidase; BST-1; cADPr hydrolase 2; bone marrow stromal antigen 1; cyclic ADP-ribose hydrolase 2;
BTC
betacellulin
BTC; betacellulin; probetacellulin; Betacellulin; Betacellulin precursor; BTC; BTC_HUMAN; OTTHUMP00000160600; OTTHUMP00000219057; Probetacellulin; OTTHUMP00000160600; OTTHUMP00000219057;
CADM1
cell adhesion molecule 1
CADM1; cell adhesion molecule 1; IGSF4, immunoglobulin superfamily, member 4 , TSLC1, tumor suppressor in lung cancer 1; BL2; IGSF4A; Necl 2; NECL2; nectin like 2; RA175; ST17; SYNCAM; SYNCAM1; CADM1_HUMAN; DKFZp686F1789; IgSF4; Immunoglobulin superfamily member 4; MGC149785; MGC51880; NECL-2; Nectin-like protein 2; SgIGSF; Spermatogenic immunoglobulin superfamily; sTSLC 1; Synaptic cell adhesion molecule; TSLC-1; TSLC1; Tumor suppressor in lung cancer 1; nectin-like 2; TSLC1/Nectin-like 2/IGSF4; immunoglobulin superfamily, member 4; immunoglobulin superfamily, member 4D variant 2; sTSLC-1;
Cadm3
cell adhesion molecule 3
CADM3; cell adhesion molecule 3; nectin-lke 1; TSLC1-like protein 1; nectin-like protein 1; synaptic cell adhesion molecule 3; immunoglobulin superfamily member 4B; immunoglobulin superfamily, member 4B; BIgR; Necl1; Tsll1; Igsf4b; Necl-1; SynCAM3;
CD244
CD244 molecule, natural killer cell receptor 2B4
2B4; NAIL; NKR2B4; Nmrk; SLAMF4; NK cell activation inducing ligand NAIL; NK cell activation-inducing ligand; NK cell type I receptor protein 2B4; h2B4; natural killer cell receptor 2B4;
CDC123
cell division cycle 123 homolog
CDC123; cell division cycle 123 homolog (S. cerevisiae); C10orf7, chromosome 10 open reading frame 7; cell division cycle protein 123 homolog; D123; PZ32; HT-1080; C10orf7; FLJ13863;
CDC25A
CDC25A cell division cycle 25 homolog A (S. pombe)
CDC25A; cell division cycle 25 homolog A (S. pombe); cell division cycle 25 homolog A (S. cerevisiae) , cell division cycle 25A; M-phase inducer phosphatase 1; CDC25A2-CAG isoform; cell division cycle 25A; dual specificity phosphatase CDC25A; CDC25A2;
CDC25C
cell division cycle 25 homolog C
CDC25C; cell division cycle 25 homolog C (S. pombe); CDC25, cell division cycle 25 homolog C (S. cerevisiae) , cell division cycle 25C; M-phase inducer phosphatase 3; PPP1R60; protein phosphatase 1; regulatory subunit 60; mitosis inducer CDC25; cell div;
CDC34
cell division cycle 34 homolog
CDC34; cell division cycle 34 homolog (S. cerevisiae); cell division cycle 34; ubiquitin-conjugating enzyme E2 R1; E2 CDC34; UBC3; UBE2R1; ubiquitin carrier protein; ubiquitin-protein ligase R1; ubiquitin-conjugating enzyme E2-CDC34; ubiquitin-conjugating;
CDC37
cell division cycle 37 homolog
CDC37; cell division cycle 37 homolog (S. cerevisiae); CDC37 (cell division cycle 37, S. cerevisiae, homolog) , CDC37 cell division cycle 37 homolog (S. cerevisiae); hsp90 co-chaperone Cdc37; CDC37 (cell division cycle 37; S. cerevisiae; homolog);
CDC42
cell division cycle 42
CDC42; cell division cycle 42; G25K; CDC42Hs; cell division control protein 42 homolog; G25K GTP-binding protein; GTP-binding protein, 25kD; growth-regulating protein; GTP binding protein, 25kDa; small GTP binding protein CDC42; dJ224A6.1.1 (cell division cycle 42 (GTP-binding protein, 25kD)); dJ224A6.1.2 (cell division cycle 42 (GTP-binding protein, 25kD));
CDC6
cell division cycle 6 homolog
CDC6; cell division cycle 6 homolog (S. cerevisiae); CDC6 (cell division cycle 6, S. cerevisiae) homolog , CDC6 cell division cycle 6 homolog (S. cerevisiae) , CDC18L; cell division control protein 6 homolog; p62(cdc6); CDC6-related protein; cdc18-relate;
CDCA8
cell division cycle associated 8
CDCA8; cell division cycle associated 8; borealin; BOR; DasraB; FLJ12042; MESRGP; Dasra B; dasra-B; hDasra-B; cell division cycle-associated protein 8; pluripotent embryonic stem cell-related gene 3 protein; FLJ10468;
CEACAM1
CEACAM1 carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
CEACAM1; carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein); BGP; carcinoembryonic antigen-related cell adhesion molecule 1; BGP1; CD66a; antigen CD66; CD66a antigen; BGPI; Arcitumomab; CEA-Scan; 154361-48-5;
CEACAM3
carcinoembryonic antigen-related cell adhesion molecule 3
CEACAM3; carcinoembryonic antigen-related cell adhesion molecule 3; CGM1; CD66d; CD66d antigen; carcinoembryonic antigen CGM1; nonspecific cross-reacting antigen; carcinoembryonic antigen gene family member 1; CEA; W264; W282; CD66D; MGC119875;
CEACAM5
carcinoembryonic antigen-related cell adhesion molecule 5
CEACAM5; carcinoembryonic antigen-related cell adhesion molecule 5; CEA; CD66e; meconium antigen 100; DKFZp781M2392;
CEACAM6
CEACAM6 carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
CEACAM6; carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen); NCA; CEAL; CD66c; carcinoembryonic antigen-related cell; CD66c antigen; Non-specific crossreacting antigen; carcinoembryonic antigen-related cell; adhesion molecule 6; Sulesomab; LeukoScan; 167747-19-5;
CEACAM8
carcinoembryonic antigen-related cell adhesion molecule 8
CEACAM8; carcinoembryonic antigen-related cell adhesion molecule 8; CGM6; CD66b; CD67 antigen; carcinoembryonic antigen CGM6; non-specific cross-reacting antigen NCA-95; carcinoembryonic antigen gene family member 6; CD67; NCA-95;
CHL1
cell adhesion molecule with homology to L1CAM
CHL1; cell adhesion molecule with homology to L1CAM; neural cell adhesion molecule L1-like protein; CALL; Cell adhesion molecule with homology to L1CAM (close homolog of L1); Cell adhesion molecule with homology to L1CAM (close homologue of L1); Close homolog of L1; FLJ44930; L1 cell adhesion molecule 2; L1CAM2; MGC132578; Neural cell adhesion molecule; chl1-like protein; LICAM2; AI465420; A530023M13Rik;
CLIC1
chloride intracellular channel 1
CLIC1; chloride intracellular channel 1; chloride intracellular channel protein 1; NCC27; p64CLCP; hRNCC; RNCC protein; chloride channel ABP; nuclear chloride ion channel 27; nuclear chloride ion channel protein; regulatory nuclear chloride ion channel pr;
CLIC2
chloride intracellular channel 2
CLIC2; chloride intracellular channel 2; chloride intracellular channel protein 2; XAP121; CLIC 2b; CLIC2_HUMAN; CLIC2b; OTTHUMP00000196471; XAP 121; OTTHUMP00000024248;
CLIC3
chloride intracellular channel 3
CLIC3; chloride intracellular channel 3; chloride intracellular channel protein 3;
CLIC4
chloride intracellular channel 4
CLIC4; chloride intracellular channel 4; chloride intracellular channel protein 4; CLIC4L; DKFZP566G223; H1; huH1; p64H1; chloride intracellular channel 4 like; intracellular chloride ion channel protein p64H1; MTCLIC; FLJ38640;
Cma1
chymase 1, mast cell
CMA1; chymase 1, mast cell; chymase; alpha-chymase; mast cell chymase 1; mast cell protease 5; mast cell protease I; Mcp5; Mcp-5; Mcpt5; MMCP-5;
CRABP1
cellular retinoic acid binding protein 1
CRABP1; cellular retinoic acid binding protein 1; cellular retinoic acid binding protein 1 , RBP5; cellular retinoic acid-binding protein 1; CRABP; CRABP I; CRABPI; cellular retinoic acid-binding protein I; RBP5; CRABP-I;
CRABP2
cellular retinoic acid binding protein 2
CRABP2; cellular retinoic acid binding protein 2; cellular retinoic acid-binding protein 2; CRABP II; Cellular retinoic acid binding protein II; Cellular retinoic acid-binding protein II; CRABP-II; CRABPII; RABP2_HUMAN; RBP6; OTTHUMP00000038730; OTTHUMP00000038732;
CRTAM
cytotoxic and regulatory T cell molecule
CRTAM; cytotoxic and regulatory T cell molecule; cytotoxic and regulatory T-cell molecule; CD355; class I MHC restricted T cell associated molecule; OTTHUMP00000231739; class-I MHC-restricted T cell associated molecule; class-I MHC-restricted T-cell-associated molecule;
EPCAM
epithelial cell adhesion molecule
EPCAM; epithelial cell adhesion molecule; ESA; KSA; M4S1; MK-1; DIAR5; EGP-2; EGP40; KS1/4; MIC18; TROP1; EGP314; HNPCC8; TACSTD1; antigen identified by monoclonal antibody AUA1; tumor-associated calcium signal transducer 1; 17-1A; 323/A3; CD326; CO-17A; EGP34; EGP40; GA733-2; HEA125; Ly74; MH99; MOC31; TACST-1; Adenocarcinoma-associated antigen; Cell surface glycoprotein Trop-1; Epithelial cell surface antigen; Epithelial glycoprotein; Epithelial glycoprotein 314; KS 1/4 antigen; Major gastrointestinal tumor-associated protein GA733-2; TACSTD1; human epithelial glycoprotein-2; Ep-CAM; membrane component, chromosome 4, surface marker (35kD glycoprotein); EGP; M1S2; CD326 antigen; Hegp314; ACSTD1; Adecatumumab; 503605-66-1; Citatuzumab bogatox; 945228-49-9; Citatuzumab bogatox; 945228-49-9; Tucotuzumab celmoleukin; 339986-90-2; Solitomab; 503605-66-1;
ESAM
endothelial cell adhesion molecule
ESAM; endothelial cell adhesion molecule; W117m; endothelial cell-selective adhesion molecule; 2310008D05Rik; LP4791 protein; HUEL (C4orf1)-interacting protein;
FAS
Fas cell surface death receptor
FAS; Fas cell surface death receptor; APT1; CD95; FAS1; APO-1; FASTM; ALPS1A; TNFRSF6;
FIBP
fibroblast growth factor (acidic) intracellular binding protein
FIBP;fibroblast growth factor (acidic) intracellular binding protein;acidic fibroblast growth factor intracellular-binding protein;FGFIBP;aFGF intracellular-binding protein;FGF-1 intracellular-binding protein;FIBP-1;
GDNF
glial cell derived neurotrophic factor
GDNF; glial cell derived neurotrophic factor; ATF1; ATF2; HSCR3; HFB1-GDNF; glial cell line-derived neurotrophic factor; ATF; astrocyte-derived trophic factor;
Havcr1
hepatitis A virus cellular receptor 1
HAVCR1; hepatitis A virus cellular receptor 1; TIM; KIM1; TIM1; HAVCR; KIM-1; TIM-1; TIMD1; TIMD-1; HAVCR-1; kidney injury molecule 1; T-cell membrane protein 1; T-cell immunoglobulin mucin receptor 1; T-cell immunoglobulin mucin family member 1; T cell immunoglobin domain and mucin domain protein 1;
HAVCR2
hepatitis A virus cellular receptor 2
HAVCR2; hepatitis A virus cellular receptor 2; hepatitis A virus cellular receptor 2 homolog; TIM-3; TIMD-3; HAVcr-2; T-cell membrane protein 3; T cell immunoglobulin mucin-3; T-cell immunoglobulin and mucin domain-containing protein 3; tim3;
HCK
hemopoietic cell kinase
HCK; hemopoietic cell kinase; tyrosine-protein kinase HCK; JTK9; p59-HCK/p60-HCK; hematopoietic cell kinase; p59Hck; p61Hck;
HK3
hexokinase 3 (white cell)
HK3; hexokinase 3 (white cell); hexokinase-3; HK III; hexokinase type III; ATP:D-hexose 6-phosphotransferase; HXK3; HKIII;
ICAM1
intercellular adhesion molecule 1
ICAM1; intercellular adhesion molecule 1; BB2; CD54; P3.58; ICAM-1; cell surface glycoprotein P3.58; major group rhinovirus receptor; intercellular adhesion molecule 1 (CD54), human rhinovirus receptor; ICAM;
ICAM3
intercellular adhesion molecule 3
ICAM3; intercellular adhesion molecule 3; CD50; CDW50; ICAM-R; ICAM-3; intercellular adhesion molecule-3;
ICOS
inducible T-cell co-stimulator
ICOS; inducible T-cell co-stimulator; inducible T-cell costimulator; activation inducible lymphocyte immunomediatory molecule; AILIM; CD278; inducible costimulator; activation-inducible lymphocyte immunomediatory molecule; CVID1; MGC39850;
ICOSLG
inducible T-cell co-stimulator ligand
ICOSLG; inducible T-cell co-stimulator ligand; ICOSL; ICOS ligand; B7 homolog 2; B7 homologue 2; B7 H2; B7 related protein 1; B7H2; B7RP 1; B7RP1; CD275; GL50; ICOS L; KIAA0653; B7-like protein Gl50; B7-related protein 1; transmembrane protein B7-H2 ICOS ligand; B7-H2; LICOS; B7RP-1; ICOS-L;
IKBKB
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
IKBKB; IKK2; IKKB; NFKBIKB; FLJ33771; FLJ36218; FLJ38368; FLJ40509; IKK-beta; MGC131801; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta; inhibitor of nuclear factor kappa-B kinase subunit beta; IKK-B; I-kappa-B kinase 2; OTTHUMP00000225854; OTTHUMP00000225858; OTTHUMP00000225860; OTTHUMP00000225865; OTTHUMP00000225866; I-kappa-B-kinase beta; nuclear factor NF-kappa-B inhibitor kinase beta;
IKBKE
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
IKBKE; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon; inhibitor of nuclear factor kappa-B kinase subunit epsilon; IKK i; IKKE; KIAA0151; IKK-epsilon; I-kappa-B kinase epsilon; inducible IkappaB kinase; IKK-related kinase epsilon; inducible I kappa-B kinase; IKKI; IKK-E; IKK-i; MGC125294; MGC125295; MGC125297;
IL12A
interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)
IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); NKSF1; interleukin-12 subunit alpha; CLMF; cytotoxic lymphocyte maturation factor 1; p35; IL 12; subunit p35; IL 12A; IL35 subunit; interleuk;
ITK
IL2-inducible T-cell kinase
ITK; IL2-inducible T-cell kinase; tyrosine-protein kinase ITK/TSK; EMT; LYK; PSCTK2; kinase EMT; T-cell-specific kinase; tyrosine-protein kinase LYK; IL-2-inducible T cell kinase; IL-2-inducible T-cell kinase; homolog of mouse T-cell itk/tsk; interleukin-;
KIR2DL1
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
KIR2DL1; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; killer cell immunoglobulin-like receptor 2DL1; 47.11; CD158A; cl 42; nkat1; p58.1; NKAT-1; killer Ig receptor; p58 NK receptor CL-42/47.11; MHC class I NK cell receptor; killer inhibitory receptor 2-2-1; CD158 antigen-like family member A; natural killer-associated transcript 1; p58 NK cell inhibitory receptor NKR-K6; p58.1 MHC class-I-specific NK receptor; p58 killer cell inhibitory receptor KIR-K64; p58 natural killer cell receptor clones CL-42/47.11; NKAT; KIR221; KIR-K64;
KIR2DL3
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
KIR2DL3; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3; killer cell immunoglobulin-like receptor 2DL3; CD158B2; cl 6; nkat2; nkat2a; nkat2b; p58; CD158b; GL183; Killer Cell Immunoglobulin Like Receptor 2DL3; Killer inhibitory receptor CL2 3; KIR023GB; MHC Class I NK Cell Receptor; Natural Killer Associated Transcript 2; p58 Natural Killer Cell Receptor Clone CL6; p58 NK Receptor; p58.2 MHC Class I Specific NK Receptor; NKAT-2; NK-receptor; OTTHUMP00000068619; p58 NK receptor CL-6; killer inhibitory receptor cl 2-3; CD158 antigen-like family member B2; natural kill; NKAT; KIR-K7b; KIR-K7c; KIRCL23; KIR-023GB;
KIR2DL4
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
KIR2DL4; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4; killer cell immunoglobulin-like receptor 2DL4; 15.212; 103AS; CD158D; KIR-103AS; NK cell receptor; killer Ig receptor; CD158 antigen-like family member D; MHC class;
KIR2DS4
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
KIR2DS4; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4; killer cell immunoglobulin-like receptor 2DS4; CD158i; cl 39; KKA3; nkat8; CD158 antigen like family member I; CD158i antigen; CL 17; CL17; CL39; Killer cell immunoglobulin like receptortwo domains short cytoplasmic tail 4; Killer inhibitory receptor 4 1 2; KIR antigen 2DS4; KIR1D; KIR412; MGC120019; MGC125315; MGC125317; MHC class I NK cell receptor; Natural killer associated transcript 8; Natural killer cell inhibitory receptor; NKAT 8; P58 natural killer cell receptor clone CL 39; p58 NK receptor; NKAT-8; OTTHUMP00000199030; p58 NK receptor CL-39/CL-17; killer inhibitory receptor 4-1-2; CD158 antigen-like family member I; natural killer-associated transcript 8; na;
KIR3DL1
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
KIR3DL1; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1; KIR; killer cell immunoglobulin-like receptor 3DL1; AMB11; CD158e1; CD158e1/2; CD158e2; cl 2; cl 11; nkat3; NKB1; NKB1B; CD158 antigen-like family member E; CD158E; CD158e antigen; CL11; CL2; HLA-BW4-specific inhibitory NK cell receptor; killer cell immunoglobulin like receptor; Killer cell immunoglobulin like receptor three domains , short cytoplasmic tail, 1; Killer cell immunoglobulin like receptor three domains long cytoplasmic tail 1; KIR antigen 3DL1; KIR G1; KIR3DS1; Kirl1; Kirl2; Krl1; MGC119726; MGC119728; MGC126589; MGC126591; MHC class I NK cell receptor; Natural killer associated transcript 3; Natural killer cell inhibitory receptor; NK receptor; NK-associated transcript 10; NK-associated transcript 3; NK-associated transcript 3delIg1; NKAT10; p70 killer cell inhibitory receptor; p70 natural killer cell receptor clones CL 2/CL 11; NKAT-3; NK-receptor; OTTHUMP00000068687; OTTHUMP00000068688; OTTHUMP00000081758; killer Ig receptor; p70 NK receptor CL-2/CL-11; p70 ki; KIR3DL1/S1;
L1CAM
L1 cell adhesion molecule
antigen identified by monoclonal antibody R1; CAML1; CD 171; CD171; CD171 antigen; HGNC:7086; HSAS; HSAS1; Hyd; L1; L1 cell adhesion molecule; L1-NCAM; L1cam; L1CAM_HUMAN; MASA; MIC 5; MIC5; N CAM L1; N CAML1; N-CAM-L1; NCAM-L1; NCAML1; Nerve-growth factor-inducible large external glycoprotein; Neural cell adhesion molecule L1; NEURAL CELL ADHESION MOLECULE L1 PRECURSOR; NILE; OTTHUMP00000025992; S10; SPG 1; SPG1;
LAT
linker for activation of T cells
LAT; linker for activation of T cells; linker for activation of T-cells family member 1; LAT1; transmembrane adaptor; p36-38; 36 kDa phospho-tyrosine adapter protein; 36 kDa phospho-tyrosine adaptor protein; linker for activation of T cells, transmembrane adaptor; pp36;
LAT2
linker for activation of T cells family, member 2
LAT2; linker for activation of T cells family, member 2; WBSCR5, WBSCR15, Williams Beuren syndrome chromosome region 5; linker for activation of T-cells family member 2; HSPC046; LAB; linker for activation of B cells; linker for activation of T cells; transmembrane adaptor 2; non T cell activation linker; NTAL; WSCR5; non-T-cell activation linker; linker for activation of B-cells; membrane-associated adapter molecule; Williams-Beuren syndrome chromosomal region 5 protein; Williams-Beuren syndrome chromosomal region 15 protein; linker for activation of T cells, transmembrane adaptor 2; WBSCR5; WBSCR15;
Madcam1
mucosal vascular addressin cell adhesion molecule 1
MADCAM1; mucosal vascular addressin cell adhesion molecule 1; mucosal addressin cell adhesion molecule 1; MACAM1; MAdCAM-1; hMAdCAM-1; mucosal addressin cell adhesion molecule-1;
MCAM
melanoma cell adhesion molecule
MCAM; melanoma cell adhesion molecule; cell surface glycoprotein MUC18; CD146; Gicerin; MUC18; melanoma adhesion molecule; cell surface glycoprotein P1H12; melanoma-associated antigen A32; melanoma-associated antigen MUC18; S-endo 1 endothelial-associated antigen;
MNDA
myeloid cell nuclear differentiation antigen
MNDA; myeloid cell nuclear differentiation antigen; PYHIN3;
NEDD4
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
NEDD4; neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase; RPF1; NEDD4-1; E3 ubiquitin-protein ligase NEDD4; receptor-potentiating factor 1; cell proliferation-inducing gene 53 protein; neural precursor cell expressed developmentally down-regulated protein 4;
NEDD8
neural precursor cell expressed, developmentally down-regulated 8
NEDD8; neural precursor cell expressed, developmentally down-regulated 8; Nedd 8; neddylin; ubiquitin-like protein Nedd8; NEDD-8; FLJ43224; MGC104393; MGC125896; MGC125897;
NFATC1
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
NFATC1; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1; nuclear factor of activated T-cells, cytoplasmic 1; NF ATC; NFAT2; NFATc; NF-ATc1; NFAT transcription complex cytosolic component; NF-ATC; MGC138448;
NFKB1
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
NFKB1; p50; KBF1; p105; EBP-1; MGC54151; NFKB-p50; NFkappaB; NF-kappaB; NFKB-p105; DKFZp686C01211; nuclearfactor NF-kappa-Bp105subunit; NF-kappabeta; OTTHUMP00000161765; OTTHUMP00000216418; OTTHUMP00000219572; DNA binding factor KBF1; nuclear factor NF-kappa-B p50 subunit; nuclear factor kappa-B DNA binding subunit;
NFKBIA
nuclear factor of kappa light polypeptide gene enhancer in B-cell extracts inhibitor, alpha
IKBA; MAD-3; NFKBI; I-kappa-B-alpha; IkappaBalpha; NF-kappa-B inhibitor alpha; ikB-alpha; major histocompatibility complex enhancer-binding protein MAD3; nuclear factor of kappa light chain gene enhancer in B-cells;
NME2
non-metastatic cells 2, protein (NM23B) expressed in
NME2; non-metastatic cells 2, protein (NM23B) expressed in; nucleoside diphosphate kinase B; NM23 H2; NDP kinase B; c-myc transcription factor; histidine protein kinase NDKB; nucleotide diphosphate kinase B; c-myc purine-binding transcription factor PUF;
NME3
non-metastatic cells 3, protein expressed in
NME3; non-metastatic cells 3, protein expressed in; nucleoside diphosphate kinase 3; DR nm23; NM23 H3; NDK 3; NDP kinase 3; NDP kinase C; nucleoside diphosphate kinase C; NDPKC; NDPK-C; NM23H3; DR-nm23; NM23-H3; c371H6.2; KIAA0516;
NME4
non-metastatic cells 4, protein expressed in
NME4; non-metastatic cells 4, protein expressed in; nucleoside diphosphate kinase, mitochondrial; nm23 H4; NM23H4; NDK; NDPKD; NDP kinase D; NDP kinase, mitochondrial; nucleoside diphosphate kinase D; NDPK-D; nm23-H4;
OPCML
opioid binding protein/cell adhesion molecule-like
OPCML; opioid binding protein/cell adhesion molecule-like; opioid binding protein/cell adhesion molecule like; opioid-binding protein/cell adhesion molecule; IgLON family member 1; IGLON1; OBCAM; OPCM; opioid binding protein/cell adhesion molecule-like pr;
PCNA
proliferating cell nuclear antigen
PCNA; proliferating cell nuclear antigen; cyclin; DNA polymerase delta auxiliary protein;
PDCD1
Pdcd1 programmed cell death 1
PDCD1; programmed cell death 1; programmed cell death protein 1; mPD-1; protein PD-1; PD-1; Pdc1; Ly101;
PDCD1LG2
PDCD1LG2 programmed cell death 1 ligand 2
PDCD1LG2; programmed cell death 1 ligand 2; B7 dendritic cell molecule; B7 DC; bA574F11.2; Btdc; CD273; PD L2; PDL2; B7-DC; PD-1 ligand 2; PD-1-ligand 2; PDCD1 ligand 2; butyrophilin B7-DC; programmed death ligand 2; B7DC; PD-L2; PDCD1L2; MGC142238; MGC142240;
PDCD2
programmed cell death 2
PDCD2;programmed cell death 2;programmed cell death protein 2;RP8;ZMYND7;zinc finger protein Rp-8;zinc finger MYND domain-containing protein 7;MGC12347;
PDCD4
programmed cell death 4 (neoplastic transformation inhibitor)
PDCD4; programmed cell death 4 (neoplastic transformation inhibitor); H731; programmed cell death protein 4; protein 197/15a; nuclear antigen H731; neoplastic transformation inhibitor protein;
PDCD5
programmed cell death 5
PDCD5; programmed cell death 5; programmed cell death protein 5; MGC9294; TF1 cell apoptosis related gene 19; TFAR19; TFAR19 novel apoptosis related; TFAR19 novel apoptosis-related; TF1 cell apoptosis-related gene 19; TF-1 cell apoptosis-related protein 1;
PDCD6
programmed cell death 6
PDCD6; programmed cell death 6; programmed cell death protein 6; ALG 2; apoptosis linked gene 2; PEF1B; apoptosis-linked gene-2; apoptosis-linked gene 2 protein; probable calcium-binding protein ALG-2; ALG-2; MGC9123; FLJ46208; MGC111017; MGC119050;
PDCD6IP
programmed cell death 6 interacting protein
PDCD6IP; programmed cell death 6 interacting protein; AIP1; ALIX; HP95; DRIP4; programmed cell death 6-interacting protein; PDCD6-interacting protein; ALG-2 interacting protein 1; ALG-2-interacting protein X; dopamine receptor interacting protein 4; apoptosis-linked gene 2-interacting protein X;
PECAM1
platelet/endothelial cell adhesion molecule 1
PECAM1; platelet/endothelial cell adhesion molecule 1; CD31; PECA1; GPIIA; PECAM-1; endoCAM; CD31/EndoCAM; platelet endothelial cell adhesion molecule; CD31 antigen; Pecam;
RBP5
retinol binding protein 5, cellular
RBP5;retinol binding protein 5, cellular;retinol-binding protein 5;CRBPIII;HRBPiso;retinol-binding protein 5, cellular;cellular retinol-binding protein III;putative cellular retinol-binding protein CRBP III;CRBP3;CRBP-III;
RBP7
retinol binding protein 7, cellular
RBP7; retinol binding protein 7, cellular; retinoid-binding protein 7; CRBPIV; Cellular retinoic acid binding protein 4; Cellular retinoic acid-binding protein IV; CRABP IV; CRBP4; Retinoid binding protein 7; CRABP4; CRABP-IV; cellular retinoic acid-binding protein 4; putative cellular retinol-binding protein CRBP IV;
RQCD1
RCD1 required for cell differentiation1 homolog
RQCD1; RCD1 required for cell differentiation1 homolog (S. pombe); rcd1 (required for cell differentiation, S.pombe) homolog 1; cell differentiation protein RCD1 homolog; cancer/testis antigen 129; CNOT9; CT129; RCD1; RCD1+; rcd-1; protein involved in sex;
TCL1A
T-cell leukemia/lymphoma 1A
TCL1A; T-cell leukemia/lymphoma 1A; TCL1; T-cell leukemia/lymphoma protein 1A; oncogene TCL1; oncogene TCL-1; protein p14 TCL1; T-cell lymphoma-1;
Thy1
thymus cell antigen 1, theta
THY1; thymus cell antigen 1, theta; thy-1 membrane glycoprotein; Thy 1.2; thy-1 antigen; T25; CD90; Thy-1; Thy1.1; Thy1.2; Thy-1.2;
TIGIT
T cell immunoreceptor with Ig and ITIM domains
TIGIT; T cell immunoreceptor with Ig and ITIM domains; V set and immunoglobulin domain containing 9 , V set and transmembrane domain containing 3 , VSIG9, VSTM3; T-cell immunoreceptor with Ig and ITIM domains; DKFZp667A205; FLJ39873; V-set and transmembrane domain containing 3; V-set and immunoglobulin domain containing 9; Washington University cell adhesion molecule; V-set and transmembrane domain-containing protein 3; V-set and immunoglobulin domain-containing protein 9; VSIG9; VSTM3; WUCAM;
Timd4
T-cell immunoglobulin and mucin domain containing 4
TIMD4; T-cell immunoglobulin and mucin domain containing 4; T-cell immunoglobulin and mucin domain-containing protein 4; TIM-4; TIMD-4; T-cell membrane protein 4; TIM4; SMUCKLER; FLJ27515;
TNFRSF10C
tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
TNFRSF10C; CD263; DCR1; DCR1-TNFR; LIT; TRAIL-R3; TRAILR3; TRID; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain;
TREM1
Triggering receptor expressed on myeloid cells 1
CD354; TREM-1; triggering receptor expressed on monocytes 1; triggering-receptor TREM1;
TREM2
triggering receptor expressed on myeloid cells 2
TREM2; triggering receptor expressed on myeloid cells 2; triggering receptor expressed on myeloid cells 2a; TREM 2; Trem2a; Trem2b; Trem2c; triggering receptor expressed on monocytes 2; TREM-2;
TREML2
triggering receptor expressed on myeloid cells-like 2
TREML2; triggering receptor expressed on myeloid cells-like 2; trem-like transcript 2 protein; TLT-2; triggering receptor expressed on myeloid cells-like protein 2; triggering receptor expressed on myeloid cells-like 2a dominant; Tlt2; Gm750; AW049306;
VCAM1
vascular cell adhesion molecule 1
VCAM1; vascular cell adhesion molecule 1; INCAM-100; Vascular cell adhesion protein 1 precursor; CD-10^6 antigen; CD10^6; DKFZp779G2333; MGC99561; CD10^6 antigen; OTTHUMP00000012650; OTTHUMP00000012651; L1CAM; V-CAM 1; CD106; Vcam-1;
XRCC3
X-ray repair complementing defective repair in Chinese hamster cells 3
XRCC3; X-ray repair complementing defective repair in Chinese hamster cells 3; DNA repair protein XRCC3; RAD51 like; X-ray repair cross-complementing protein 3; CMM6;
XRCC5
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
XRCC5; X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining); X ray repair complementing defective repair in Chinese hamster cells 5 (double strand break rejoining; Ku autoantigen, 80kD); X-ray repair cross-complementing protein 5; KARP 1; Ku autoantigen; 80kDa; KU80; Ku86; KUB2; TLAA; CTC85; CTCBF; nuclear factor IV; Ku autoantigen, 80kDa; DNA repair protein XRCC5; thyroid-lupus autoantigen; 86 kDa subunit of Ku antigen; lupus Ku autoantigen protein p86; Ku86 autoantigen related protein 1; CTC box-binding factor 85 kDa subunit; ATP-dependent DNA helicase 2 subunit 2; ATP-dependent DNA helicase II 80 kDa subunit; NFIV; KARP1; KARP-1; FLJ39089;
XRCC6
X-ray repair complementing defective repair in Chinese hamster cells 6
XRCC6; X-ray repair complementing defective repair in Chinese hamster cells 6; ML8; KU70; TLAA; CTC75; CTCBF; G22P1; X-ray repair cross-complementing protein 6; 5-dRP lyase Ku70; Ku autoantigen, 70kDa; DNA repair protein XRCC6; Ku autoantigen p70 subunit; 70 kDa subunit of Ku antigen; thyroid-lupus autoantigen p70; lupus Ku autoantigen protein p70; 5-deoxyribose-5-phosphate lyase Ku70; CTC box binding factor 75 kDa subunit; CTC box-binding factor 75 kDa subunit; thyroid autoantigen 70kD (Ku antigen); ATP-dependent DNA helicase 2 subunit 1; thyroid autoantigen 70kDa (Ku antigen); ATP-dependent DNA helicase II 70 kDa subunit; ATP-dependent DNA helicase II, 70 kDa subunit;
NCAM1
neural cell adhesion molecule 1
CD56; NCAM; MSK39; NCAM1; neural cell adhesion molecule 1; NCAM-1; N-CAM-1; OTTHUMP00000235666; neural cell adhesion molecule, NCAM; antigen recognized by Monoclonal 5.1H11; ANTI-CD56 Mouse; ANTI-CD56; NATURAL KILLER CELL; ANTI-CD56, NCAM; ANTI-CD56/NCAM-1 Mouse MAb; ANTI-CD56, NATURAL KILLER CELL; ANTI-SCLC; ANTI-NKH1; CD56; NCAM1; NCAM; MSK39;
MUC1
mucin 1, cell surface associated
MUC1; mucin 1, cell surface associated; EMA; MCD; PEM; PUM; KL-6; MAM6; MCKD; PEMT; CD227; H23AG; MCKD1; MUC-1; ADMCKD; ADMCKD1; CA 15-3; MUC-1/X; MUC1/ZD; MUC-1/SEC; mucin-1; episialin; DF3 antigen; H23 antigen; cancer antigen 15-3; krebs von den Lungen-6; mucin 1, transmembrane; carcinoma-associated mucin; polymorphic epithelial mucin; peanut-reactive urinary mucin; tumor associated epithelial mucin; breast carcinoma-associated antigen DF3; tumor-associated epithelial membrane antigen;
MUC16
mucin 16, cell surface associated
MUC16; mucin 16, cell surface associated; CA125; mucin-16; CA-125; MUC-16; CA125 ovarian cancer antigen; ovarian carcinoma antigen CA125; ovarian cancer-related tumor marker CA125; FLJ14303; Igovomab; Indimacis-125; 171656-50-1; Abagovomab; 792921-10-9;
BCL3
B-cell CLL/lymphoma 3
BCL4; D19S37; BCL3; B-cell lymphoma 3 protein; BCL-3; OTTHUMP00000200151; OTTHUMP00000200152; proto-oncogene BCL3; B-cell leukemia/lymphoma 3; B-cell lymphoma 3-encoded protein; chronic lymphatic leukemia protein;
DEFA5
defensin, alpha 5, Paneth cell-specific
DEFA5; defensin, alpha 5, Paneth cell-specific; DEF5; defensin-5; HD 5; defensin 5; defensin, alpha 5, preproprotein; HD-5; MGC129728;
DEFA6
defensin, alpha 6, Paneth cell-specific
DEFA6; defensin, alpha 6, Paneth cell-specific; defensin-6; DEF6; HD 6; alpha 6; DEF6_HUMAN; DEFA 6; Defensin 6; Defensin alpha 6; Defensin alpha 6 Paneth cell specific; Defensin; HD6; OTTHUMP00000115425; HD-6;
Tcrg
T-cell receptor gamma chain
TCRG; T-cell receptor gamma chain; T cell antigen receptor gamma subunit; T cell rearranging gene gamma; T cell receptor gamma locus; T cell receptor gamma v region; tarp included; tcrg alternate reading frame protein included; TCRGV1S1; TCRGV2S1; TCRGV3S1; TCRGV5S3;
MTBP
Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa
MTBP; Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa; MDM2 (mouse double minute 2) binding protein, 104kD; mdm2-binding protein; hMTBP; MDM2 (mouse double minute 2)-binding protein, 104kD; MDM2BP;
NEDD9
neural precursor cell expressed, developmentally down-regulated 9
NEDD9; neural precursor cell expressed, developmentally down-regulated 9; CAS2; CASL; HEF1; CAS-L; CASS2; enhancer of filamentation 1; cas-like docking; p130Cas-related protein; Enhancer of filamentation 1 p55; renal carcinoma antigen NY-REN-12; Cas scaffolding protein family member 2; Crk-associated substrate related protein Cas-L; neural precursor cell expressed developmentally down-regulated protein 9;
KLRD1
killer cell lectin-like receptor subfamily D, member 1
KLRD1; killer cell lectin-like receptor subfamily D, member 1; CD94; natural killer cells antigen CD94; KP43; CD94 antigen; NK cell receptor;
Lcam1
Intercellular Adhesion Molecule 1
CD54; Ly-47; Icam-1; MALA-2; MGC6195; Icam1; intercellular adhesion molecule 1; myD10;
Cdc25b
cell division cycle 25 homolog B
CDC25B; cell division cycle 25 homolog B (S. pombe); cell division cycle 25 homolog B (S. cerevisiae) , cell division cycle 25B; M-phase inducer phosphatase 2; cell division cycle 25B; dual specificity phosphatase Cdc25B;
NFKB2
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100); nuclear factor NF-kappa-B p100 subunit; LYT 10; NF kB2; p52; p105; oncogene Lyt-10; DNA-binding factor KBF2; lymphocyte translocation chromosome 10 protein; nuclear fa;
NFKBIB
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
NFKBIB; IKBB; TRIP9; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; NF-kappa-B inhibitor beta; ikB-B; TRIP-9; ikB-beta; ikappaBbeta; NF-kappa-BIB; I-kappa-B-beta; TR-interacting protein 9; thyroid receptor-interacting protein 9;
NFKBIE
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
NFKBIE; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon; NF-kappa-B inhibitor epsilon; IKBE; ikB-E; ikB-epsilon; NF-kappa-BIE; ikappaBepsilon; I-kappa-B-epsilon;
HCLS1
hematopoietic cell-specific Lyn substrate 1
HCLS1; hematopoietic cell-specific Lyn substrate 1; hematopoietic lineage cell-specific protein; cortactin like; CTTNL; HS1; p75; lckBP1;
BST2
bone marrow stromal cell antigen 2
BST2; bone marrow stromal cell antigen 2; bone marrow stromal antigen 2; CD317; tetherin; BST-2; NPC-A-7; HM1.24 antigen;
CDCA4
cell division cycle associated 4
CDCA4; cell division cycle associated 4; cell division cycle-associated protein 4; FLJ20764; hematopoietic progenitor protein; Hepp; SEI-3/HEPP; FLJ52878; MGC19517;
BCAP29
B-cell receptor-associated protein 29
BCAP29; B-cell receptor-associated protein 29; BAP29; FLJ53907; DKFZp686M2086; BCR-associated protein 29; OTTHUMP00000206633; OTTHUMP00000206634; OTTHUMP00000206639; OTTHUMP00000214583; OTTHUMP00000214584; OTTHUMP00000214585; OTTHUMP00000214586;
BCAP31
B-cell receptor-associated protein 31
CAP31; B-cell receptor-associated protein 31; CDM; BAP31; 6C6-AG; DXS1357E; BCR-associated protein 31; 6C6-AG tumor-associated antigen; Protein CDM; p28; OTTHUMP00000025977; OTTHUMP00000025978; OTTHUMP00000025979; OTTHUMP00000025981; OTTHUMP00000025983; BCR-associated;
BCL7B
B-cell CLL/lymphoma 7B
BCL7B; B-cell CLL/lymphoma 7B; B-cell CLL/lymphoma 7 protein family member B; B cell CLL/lymphoma 7 protein family member B; B cell CLL/lymphoma 7B; BCL 7B; OTTHUMP00000160391; OTTHUMP00000211550;
BCL7C
B-cell CLL/lymphoma 7C
BCL7C; B-cell CLL/lymphoma 7C; B-cell CLL/lymphoma 7 protein family member C; B cell CLL/lymphoma 7 protein family member C; B cell CLL/lymphoma 7C; BCL 7C; OTTHUMP00000163247; OTTHUMP00000163248;
BCL9
B-cell CLL/lymphoma 9
BCL9; B-cell CLL/lymphoma 9; LGS; B-cell CLL/lymphoma 9 protein; bcl-9; protein legless homolog; B-cell lymphoma 9 protein;
BTG4
B-cell translocation gene 4
BTG4; B-cell translocation gene 4; protein BTG4; PC3B; B cell translocation gene 4; BTG family member 4; MGC33003; Protein PC3b;
CDC14A
CDC14 cell division cycle 14 homolog A (S. cerevisiae)
CDC14A; CDC14 cell division cycle 14 homolog A (S. cerevisiae); CDC10 (cell division cycle 10, S. cerevisiae, homolog); dual specificity protein phosphatase CDC14A; cdc14; Cdc14A1; Cdc14A2; CDC 10; Cdc 14; Cdc 14A; Cdc 14A1; Cdc 14A2; CDC10; CDC14 cell division cycle 14 homolog A; CDC14 homolog A; Cell Division Cycle 14 Homolog A; Dual specificity protein phosphatase CDC 14A; hCDC 14; hCDC14; OTTHUMP00000012653; OTTHUMP00000012654; OTTHUMP00000012655; OTTHUMP00000012656;
CDC37L1
cell division cycle 37 homolog-like 1
CDC37L1; cell division cycle 37 homolog (S. cerevisiae)-like 1; CDC37 cell division cycle 37 homolog (S. cerevisiae) like 1 , cell division cycle 37 homolog (S. cerevisiae) like 1; hsp90 co-chaperone Cdc37-like 1; CDC37B; FLJ20639; HARC; Hsp90-associatin;
CDC45
cell division cycle 45 homolog (S. cerevisiae)
CDC45L; CDC45L2; PORC-PI-1; cell division control protein 45 homolog; human CDC45; OTTHUMP00000197247; OTTHUMP00000197248; CDC45-related protein; cell division cycle 45-like 2; CDC45 cell division cycle 45 homolog; CDC45; cell division cycle 45 homolog (S. cerevisiae);
CDCA3
cell division cycle associated 3
CDCA3; cell division cycle associated 3; GRCC8; TOME 1; trigger of mitotic entry 1;
CGREF1
cell growth regulator with EF-hand domain 1
CGREF1; cell growth regulator with EF-hand domain 1; cell growth regulator with EF hand domain protein 1; CGR11; Cell growth regulator with EF hand domain 1; Cell growth regulatory gene 11; Cell growth regulatory gene 11 protein; CGR 11; CGREF 1; hydrophobestin; OTTHUMP00000200952; OTTHUMP00000200954; OTTHUMP00000200955; OTTHUMP00000200956; OTTHUMP00000200957;
CIDEB
cell death-inducing DFFA-like effector b
CIDEB; cell death-inducing DFFA-like effector b; cell death activator CIDE-B;
CLIC5
chloride intracellular channel 5
CLIC5; chloride intracellular channel 5; chloride intracellular channel protein 5; MST130; MSTP130; FLJ90663;
CREG1
cellular repressor of E1A-stimulated genes 1
CREG1; cellular repressor of E1A-stimulated genes 1; cellular repressor of E1A stimulated genes , CREG; protein CREG1; CREG;
DAD1
Defender Against Cell Death 1
OST2; DAD1; Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1; Oligosaccharyl transferase subunit DAD1; EC=2.4.1.119; Defender against cell death 1; AD-1; OTTHUMP00000164488; OTTHUMP00000239715; OTTHUMP00000239717; DAD-1; dolichyl-diphosphooligosaccharide--protein glycosyltransfe-rase subunit DAD1; EC 2.4.1.119; oligosaccharyltransferase 2 homolog;
EBF1
early B-cell factor 1
EBF1; early B-cell factor 1; early B cell factor , EBF; transcription factor COE1; OLF1; COE1; Early B cell factor 1; EBF; O/E 1; OE-1; OTTHUMP00000160817; OTTHUMP00000224200; OTTHUMP00000224217; olfactory neuronal transcription factor 1; Collier, Olf and EBF transcription factor 1; O/E-1;
FLVCR1
feline leukemia virus subgroup C cellular receptor 1
FLVCR1; feline leukemia virus subgroup C cellular receptor 1; PCA; AXPC1; FLVCR; PCARP; MFSD7B; feline leukemia virus subgroup C receptor-related protein 1;
FZR1
fizzy/cell division cycle 20 related 1
FZR1; fizzy/cell division cycle 20 related 1 (Drosophila); fizzy-related protein homolog; CDC20C; CDH1; FZR; FZR2; HCDH; HCDH1; KIAA1242; CDC20-like 1b; cdh1/Hct1 homolog; CDC20-like protein 1;
GCM1
glial cells missing homolog 1
GCM1; glial cells missing homolog 1 (Drosophila); GCMA, glial cells missing (Drosophila) homolog a; chorion-specific transcription factor GCMa; hGCMa; GCM motif protein 1; GCMA;
ICA1
islet cell autoantigen 1, 69kDa
ICA1; islet cell autoantigen 1, 69kDa; islet cell autoantigen 1 (69kD); islet cell autoantigen 1; ICAp69; 69 kDa islet cell autoantigen; Diabetes mellitus type I autoantigen; ICA 1; ICA69; ICA69_HUMAN; Islet cell autoantigen 1 69kDa; Islet cell autoantigen 1 isoform; Islet cell autoantigen p69; OTTHUMP00000200933; OTTHUMP00000200934; OTTHUMP00000200941; OTTHUMP00000200993; p69;
IKBKAP
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein; IKBKAP; FD; DYS; ELP1; IKAP; IKI3; TOT1; FLJ12497; DKFZp781H1425; elongator complex protein 1; p150; OTTHUMP00000021869; IKK complex-associated protein; ikappaB kinase complex-associated protein;
IKBKG
IKBKG inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; incontinentia pigmenti , IP1, IP2; NF-kappa-B essential modulator; FIP 3; FIP3; Fip3p; IKK gamma; NEMO; IKKG; IKKAP1; incontinentia pigmenti; IkB kinase gamma subunit; ikB kinase subunit gamma; NFkappaB essential modulator; NF-kappa-B essential modifier; I-kappa-B kinase subunit gamma; ikB kinase-associated protein 1; inhibitor of nuclear factor kappa-B kinase subunit gamma; IP; IP1; IP2; IPD2; FIP-3; AMCBX1; IKK-gamma;
KLRB1
killer cell lectin-like receptor subfamily B, member 1
KLRB1; killer cell lectin-like receptor subfamily B, member 1; NKR; CD161; CLEC5B; NKR-P1; NKRP1A; NKR-P1A; hNKR-P1A; killer cell lectin-like receptor subfamily B member 1; C-type lectin domain family 5 member B; natural killer cell surface protein P1A;
KLRC3
killer cell lectin-like receptor subfamily C, member 3
KLRC3; killer cell lectin-like receptor subfamily C, member 3; NKG2-E type II integral membrane protein; NKG2 E; Killer cell lectin like receptor subfamily C member 3; KLRC 3; NK cell receptor E; NKG2 E activating NK receptor; NKG2 E type II integral membrane protein; NKG2-E-activating NK receptor; NKG2E activating NK receptor; NKG2E; NKG2E type II integral membrane protein; NKG2E_HUMAN; OTTHUMP00000235359; OTTHUMP00000235362; NKG2-E;
LIMS1
LIM and senescent cell antigen-like domains 1
LIMS1; LIM and senescent cell antigen-like domains 1; PINCH; PINCH1; PINCH-1; LIM and senescent cell antigen-like-containing domain protein 1; renal carcinoma antigen NY-REN-48; particularly interesting new Cys-His protein 1;
MAK
male germ cell-associated kinase
MAK; male germ cell-associated kinase; serine/threonine-protein kinase MAK; dJ417M14.2; serine/threonine protein kinase MAK; male germ cell-associated kinase retinal-enriched isoform; RP62;
MCF2L
MCF.2 cell line derived transforming sequence-like
MCF2L; MCF.2 cell line derived transforming sequence-like; guanine nucleotide exchange factor DBS; ARHGEF14; DBS; KIAA0362; OST; DBLs big sister; MCF2 transforming sequence-like protein; FLJ12122;
MCL1
myeloid cell leukemia sequence 1 (BCL2-related)
MCL1; myeloid cell leukemia sequence 1 (BCL2-related); induced myeloid leukemia cell differentiation protein Mcl-1; BCL2L3; Mcl 1; bcl-2-like protein 3; myeloid cell leukemia ES; bcl-2-related protein EAT/mcl1; TM; EAT; MCL1L; MCL1S; Mcl-1; MCL1-ES; bcl2-L-3; mcl1/EAT; MGC1839; MGC104264; myeloid cell leukemia sequence 1, isoform 1;
MUC4
mucin 4, cell surface associated
MUC4; mucin 4, cell surface associated; ASGP; MUC-4; HSA276359; mucin-4; testis mucin; tracheobronchial mucin; ascites sialoglycoprotein; mucin 4, tracheobronchial; pancreatic adenocarcinoma mucin;
NEDD1
neural precursor cell expressed, developmentally down-regulated 1
NEDD1; neural precursor cell expressed, developmentally down-regulated 1; protein NEDD1; GCP WD; TUBGCP7; NEDD-1; neural precursor cell expressed developmentally down-regulated protein 1; GCP-WD; FLJ35902;
NFAT5
nuclear factor of activated T-cells 5, tonicity-responsive
NFAT5; nuclear factor of activated T-cells 5, tonicity-responsive; nuclear factor of activated T-cells 5; KIAA0827; NF AT5; NFATL1; NFATZ; OREBP; TONEBP; NFAT-like protein 1; TonE-binding protein; glutamine rich protein H65; T-cell transcription factor NF;
NFATC2
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
NFATC2; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2; nuclear factor of activated T-cells, cytoplasmic 2; NF ATP; NFAT1; NFATp; NF-ATc2; NFAT pre-existing subunit; T cell transcription factor NFAT1; T-cell transcription factor;
NFATC2IP
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 interacting protein
NFATC2IP; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 interacting protein; NFATC2-interacting protein; ESC2; FLJ14639; NIP45; RAD60; cytoplasmic 2-interacting protein; 45 kDa NF-AT-interacting protein; 45 kDa NFAT-interacting protein; NF2IP_HUMAN; Nuclear factor of activated T-cells; Nuclear factor of activated T-cells, cytoplasmic 2-interacting protein; OTTHUMP00000123395;
NFATC3
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
NFATC3; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3; nuclear factor of activated T-cells, cytoplasmic 3; NFAT4; NFATX; NF-ATc3; T cell transcription factor NFAT4; nuclear factor of activated T-cells c3 isoform IE-Xa;
PBX1
pre-B-cell leukemia homeobox 1
PBX1; pre-B-cell leukemia homeobox 1; pre B cell leukemia transcription factor 1; pre-B-cell leukemia transcription factor 1; homeobox protein PRL; homeobox protein PBX1; MGC126627; DKFZp686B09108;
PBX3
pre-B-cell leukemia homeobox 3
PBX3; pre-B-cell leukemia homeobox 3; pre B cell leukemia transcription factor 3; pre-B-cell leukemia transcription factor 3; homeobox protein PBX3;
PBX4
pre-B-cell leukemia homeobox 4
PBX4; pre-B-cell leukemia homeobox 4; pre B cell leukemia transcription factor 4; pre-B-cell leukemia transcription factor 4; OTTMUSP00000045221; 2410015M21Rik; AI429113; AW045266; Edg4; Endothelial differentiation, lysophosphatidic acid G protein coupled receptor 4; Homeobox protein PBX4; PBX4_HUMAN;
PDCD11
programmed cell death 11
PDCD11; programmed cell death 11; protein RRP5 homolog; ALG 4; KIAA0185; RRP5; apoptosis-linked gene 4; NF-kappa-B-binding protein; programmed cell death protein 11; ALG4; NFBP; ALG-4;
PDCD2L
programmed cell death 2-like
PDCD2L; programmed cell death 2-like; programmed cell death protein 2-like; MGC13096; MGC144595; Programmed cell death 2 like; Programmed cell death protein 2 like;
PDCD7
programmed cell death 7
PDCD7; programmed cell death 7; programmed cell death protein 7; ES18; HES18; U11/U12 snRNP 59K; apoptosis-related protein ES18; FLJ54213; MGC22015;
SOD3
superoxide dismutase 3, extracellular
SOD3; superoxide dismutase 3, extracellular; EC-SOD; extracellular superoxide dismutase [Cu-Zn];
SPON1
spondin 1, extracellular matrix protein
SPON1; spondin 1, extracellular matrix protein; f-spondin; VSGP/F-spondin; spondin-1; spondin 1, (f-spondin) extracellular matrix protein; vascular smooth muscle cell growth-promoting factor;
TAX1BP1
Tax1 (human T-cell leukemia virus type I) binding protein 1
TAX1BP1; Tax1 (human T-cell leukemia virus type I) binding protein 1; tax1-binding protein 1; CALCOCO3; TXBP151; TRAF6-binding protein; T6BP;
TAX1BP3
Tax1 (human T-cell leukemia virus type I) binding protein 3
TAX1BP3; Tax1 (human T-cell leukemia virus type I) binding protein 3; tax1-binding protein 3; Tax interaction protein 1; TIP 1; Glutaminase interacting protein 3; Glutaminase-interacting protein 3; Tax1 binding protein 3; TIP-1; TIP1; TX1B3_HUMAN; OTTHUMP00000115871;
TCF7L1
transcription factor 7-like 1 (T-cell specific, HMG-box)
TCF7L1; transcription factor 7-like 1 (T-cell specific, HMG-box); TCF3; transcription factor 7-like 1; OTTMUSP00000023419; T cell factor 3; TCF 3; bHLHb21; HMG box transcription factor; Transcription factor 7 like 1 (T-cell specific, HMG-box); Transcription factor 7 like 1; OTTHUMP00000160497; HMG box transcription factor 3; TCF-3;
TCF7L2
transcription factor 7-like 2 (T-cell specific, HMG-box)
TCF7L2; transcription factor 7-like 2 (T-cell specific, HMG-box); TCF4; transcription factor 7-like 2; TCF 4; hTCF-4; T-cell factor 4; T-cell factor-4 variant A; T-cell factor-4 variant B; T-cell factor-4 variant C; T-cell factor-4 variant D; T-cell facto;
TCL1B
T-cell leukemia/lymphoma 1B
TCL1B; T-cell leukemia/lymphoma 1B; T-cell leukemia/lymphoma protein 1B; TML1; Oncogene TCL1B; SYN 1; SYN1; Syncytiotrophoblast specific protein; T cell leukemia/lymphoma 1B; T cell leukemia/lymphoma protein 1B; T cell lymphoma/leukemia 1B; TCL 1B; TCL1/ MTCP1 like 1; TML 1; oncogene TCL-1B; OTTHUMP00000195765; TCL1/ MTCP1-like 1; T-cell lymphoma/leukemia 1B; syncytiotrophoblast-specific protein; SYN-1;
TIAM2
T-cell lymphoma invasion and metastasis 2
TIAM2; T-cell lymphoma invasion and metastasis 2; T-lymphoma invasion and metastasis-inducing protein 2; STEF; FLJ41865; SIF and TIAM1 like exchange factor; SIF and TIAM1-like exchange factor; T cell lymphoma invasion and metastasis 2; T lymphoma invasion and metastasis inducing protein 2; TIAM 2; TIAM-2; TIAM2_HUMAN; OTTHUMP00000017472; OTTHUMP00000231963; OTTHUMP00000231964; OTTHUMP00000231965; OTTHUMP00000231968; OTTHUMP00000238735; OTTHUMP00000238736;
TLX3
T-cell leukemia homeobox 3
TLX3; T-cell leukemia homeobox 3; homeo box 11 like 2 , HOX11L2, T cell leukemia, homeobox 3; T-cell leukemia homeobox protein 3; RNX; homeo box 11-like 2; homeobox protein Hox-11L2; T-cell leukemia, homeobox 3; HOX11L2; MGC29804;
TRD@
T cell receptor delta locus
T cell receptor delta locus; TRD@; TRD; TCRD; TCRDV1; FLJ52034; FLJ52576; FLJ53668; FLJ54555; FLJ55265; FLJ56790; T-cell receptor, delta (V,D,J,C); T-cell antigen receptor, delta polypeptide; T-Cell Receptor Pan gamma;
VTCN1
V-set domain containing T cell activation inhibitor 1
VTCN1; V-set domain containing T cell activation inhibitor 1; V-set domain-containing T-cell activation inhibitor 1; B7 family member; H4; B7 superfamily member 1; B7 H4; B7H4; B7S1; B7X; FLJ22418; B7 family member, H4; T cell costimulatory molecule B7x; T-cell costimulatory molecule B7x; immune costimulatory protein B7-H4; B7-H4; B7h.5; VCTN1; PRO1291; RP11-229A19.4;
XRCC4
X-ray repair complementing defective repair in Chinese hamster cells 4
XRCC4; X-ray repair complementing defective repair in Chinese hamster cells 4; DNA repair protein XRCC4; X ray repair; complementing defective; repair in Chinese hamster; X-ray repair cross-complementing protein 4; X-ray repair, complementing defective, r;
XRCC1
X-ray repair complementing defective repair in Chinese hamster cells 1
XRCC1; X-ray repair complementing defective repair in Chinese hamster cells 1; RCC; DNA repair protein XRCC1; X-ray repair cross-complementing protein 1; X-ray-repair, complementing defective, repair in Chinese hamster;
RBP1
retinol binding protein 1, cellular
RBP1; retinol binding protein 1, cellular; retinol-binding protein 1; CRABP I; CRBP; CRBP1; CRBPI; RBPC; CRBP-I; cellular retinol-binding protein I; retinol-binding protein 1, cellular; CRABP-I;
NFKBIZ
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
NFKBIZ; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta; NF-kappa-B inhibitor zeta; FLJ34463; MAIL; ikB-zeta; ikappaBzeta; IkappaB-zeta; I-kappa-B-zeta; Ikappa B-zeta variant 3; IL-1 inducible nuclear ankyrin-repeat prot;
CDON
cell adhesion associated, oncogene regulated
CDON; cell adhesion associated, oncogene regulated; CDO; CDON1; HPE11; ORCAM; cell adhesion molecule-related/down-regulated by oncogenes; Cdon homolog; surface glycoprotein, Ig superfamily member;
TREML1
triggering receptor expressed on myeloid cells-like 1
TREML1; triggering receptor expressed on myeloid cells-like 1; trem-like transcript 1 protein; dJ238O23.3; TLT1; TREM like transcript 1; triggering receptor expressed on myeloid cells-like protein 1; TLT-1; PRO3438; GLTL1825; MGC119173;
AAMP
angio-associated, migratory cell protein
AAMP; angio-associated, migratory cell protein; angio-associated migratory cell protein;
BCL11A
B-cell CLL/lymphoma 11A (zinc finger protein)
BCL11A; B-cell CLL/lymphoma 11A (zinc finger protein); ecotropic viral integration site 9 , EVI9; B-cell lymphoma/leukemia 11A; BCL11A L; BCL11A S; BCL11A XL; CTIP1; HBFQTL5; ZNF856; EVI-9; BCL-11A; zinc finger protein 856; C2H2-type zinc finger protein;
BLID
BH3-like motif containing, cell death inducer
BLID; BH3-like motif containing, cell death inducer; BH3-like motif-containing cell death inducer; BRCC2; breast cancer cell 2; OTTHUMP00000231802; breast cancer cell protein 2;
CDC23
cell division cycle 23 homolog
CDC23; cell division cycle 23 homolog (S. cerevisiae); CDC23 (cell division cycle 23, yeast, homolog); cell division cycle protein 23 homolog; ANAPC8; anaphase promoting complex subunit 8; APC8; CUT23; cyclosome subunit 8; anaphase-promoting complex subun;
CDC2L2
cell division cycle 2-like 2 (PITSLRE proteins)
CDC2L2;cell division cycle 2-like 2 (PITSLRE proteins);CDC2L2, CDC2L3, cell division cycle 2 like 2, cell division cycle 2 like 2 (PITSLRE proteins);cell division cycle 2-like 2;CDK11 p46;CDK11 p58;CDK11 p110;p58GTA;PITSLRE;CDC2L3;CDK11-p46;CDK11-p58;CDK11-p110;MGC131975;Q9UQ88;cyclin-dependent kinase 11A;EC 2.7.11.22;OTTHUMP00000000760;OTTHUMP00000000762;OTTHUMP00000000763;OTTHUMP00000000764;OTTHUMP00000000767;Cell division cycle 2-like protein kinase 2;OTTHUMP00000000768;Cell division protein kinase 11A;PITSLRE B;Galactosyltransferase-associated protein kinase p58/GTA;PITSLRE protein kinase beta;PITSLREB;PITSLRE serine/threonine-protein kinase CDC2L2;EC 2.7.11;
CDC45L
CDC45 cell division cycle 45 homolog (S. cerevisiae)
CDC45L; CDC45L2; PORC-PI-1; cell division control protein 45 homolog; human CDC45; OTTHUMP00000197247; OTTHUMP00000197248; CDC45-related protein; cell division cycle 45-like 2; CDC45 cell division cycle 45 homolog;
CDC5L
cell division cycle 5-like
CDC5L; cell division cycle 5-like; CDC5; CEF1; PCDC5RP; CDC5-LIKE; dJ319D22.1; cell division cycle 5-like protein; Cdc5-related protein; pombe cdc5-related protein; dJ319D22.1 (CDC5-like protein); CDC5 cell division cycle 5-like;
CDC7
cell division cycle 7 homolog
CDC7; cell division cycle 7 homolog (S. cerevisiae); CDC7 (cell division cycle 7, S. cerevisiae, homolog) like 1 , CDC7 cell division cycle 7 (S. cerevisiae) , CDC7L1, cell division cycle 7 (S. cerevisiae); cell division cycle 7-related protein kinase;
CEL
carboxyl ester lipase
CEL; carboxyl ester lipase; BAL; FAP; BSDL; BSSL; CELL; FAPP; LIPA; CEase; MODY8; bile salt-activated lipase; bucelipase; sterol esterase; cholesterol esterase; carboxyl ester hydrolase; fetoacinar pancreatic protein; lysophospholipase, pancreatic; bile salt-dependent lipase, oncofetal isoform; carboxyl ester lipase (bile salt-stimulated lipase);
CIDEA
cell death-inducing DFFA-like effector a
CIDEA; cell death-inducing DFFA-like effector a; cell death activator CIDE-A; CIDE A; CIDE-A;
CIDEC
cell death-inducing DFFA-like effector c
cell death-inducing DFFA-like effector c; CIDEC; FSP27; CIDE-3; FLJ20871; cell death activator CIDE-3; OTTHUMP00000158645; OTTHUMP00000207602; fat specific protein 27; Cell Death Inducing DFFA Like Effector C; Cell death inducing DFFA like effector protein C; Cell death-inducing DFFA-like effector protein C; CIDE3; CIDEC_HUMAN; Fat-specific protein FSP27 homolog; CIDEX;
CPA3
carboxypeptidase A3 (mast cell)
CPA3; carboxypeptidase A3 (mast cell); mast cell carboxypeptidase A; carboxypeptidase A; Carboxypeptidase A3; carboxypeptidase A3 mast cell; CBPA3_HUMAN; mast cell carboxypeptidase A3; MC CPA; MC-CPA;
EFEMP2
EGF containing fibulin-like extracellular matrix protein 2
EFEMP2; EGF containing fibulin-like extracellular matrix protein 2; MBP1; UPH1; FBLN4; ARCL1B; EGF-containing fibulin-like extracellular matrix protein 2; FIBL-4; fibulin 4; fibulin-4; mutant p53 binding protein 1;
ELMO2
engulfment and cell motility 2
ELMO2; engulfment and cell motility 2; engulfment and cell motility 2 (ced 12 homolog, C. elegans); engulfment and cell motility protein 2; CED 12; CED12; ELMO 2; FLJ11656; KIAA1834; Ced 12 homolog 2; CED 12 homolog A; CED 12A; CED12 homolog A; CED12A; hCED 12A; hCED12A; PH domain protein CED12A; Protein ced 12 homolog A; hCed-12A; ced-12 homolog 2; OTTHUMP00000031762; OTTHUMP00000031764; OTTHUMP00000031765; protein ced-12 homolog A; CED-12; ELMO-2;
HIRA
histone cell cycle regulator
HIRA; histone cell cycle regulator; TUP1; DGCR1; TUPLE1; protein HIRA; DiGeorge critical region gene 1; TUP1-like enhancer of split protein 1; HIR histone cell cycle regulation defective homolog A;
KIR2DL2
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
KIR2DL2; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2; killer cell immunoglobulin-like receptor 2DL2; CD158B1; CD158k; cl 43; nkat6; CD158 antigen-like family member B1; CD158b; KI2L2_HUMAN; MHC class I NK cell receptor; Natural killer-associated transcript 6; NKAT 6; NKAT-6; p58 natural killer cell receptor clone CL-43; p58 NK receptor CL-43; p58.2;
KLRA1
killer cell lectin-like receptor, subfamily A, member2
KLRA1; killer cell lectin-like receptor, subfamily A, member 1; T-cell surface glycoprotein YE1/48; ly-49a; lymphocyte antigen 49a; t lymphocyte antigen A1; class I MHC receptor KLRA22; natural killer cell receptor Ly49A; novel killer cell lectin-like receptor subfamily A protein; A1; Ly49a; Ly49v; Klra22; Ly49oCH29-493D4.3; Klra1; killer cell lectin-like receptor, subfamily A, member2;
KLRC1
killer cell lectin-like receptor subfamily C, member 1
KLRC1; killer cell lectin-like receptor subfamily C, member 1; NKG2-A/NKG2-B type II integral membrane protein; NKG2A; NKG2B; CD159a;
KLRC4
killer cell lectin-like receptor subfamily C, member 4
KLRC4; killer cell lectin-like receptor subfamily C, member 4; NKG2-F type II integral membrane protein; NKG2 F; NK cell receptor F; NKG2-F-activating NK receptor; NKG2F; NKG2F_HUMAN; natual killer cell group 2-F; NKG2-F;
LECT2
leukocyte cell-derived chemotaxin 2
LECT2; leukocyte cell-derived chemotaxin 2; leukocyte cell-derived chemotaxin-2; chm II; chm2; Chondromodulin II; hLECT2; LECT 2; Leukocyte cell derived chemotaxin 2; MGC126628; chondromodulin-II; OTTHUMP00000159422; OTTHUMP00000223349; OTTHUMP00000228311; chm-II;
MTCP1
mature T-cell proliferation 1
MTCP1; mature T-cell proliferation 1; protein p13 MTCP-1; p8MTCP1; P13MTCP1; MTCP-1 type B1; mature T-cell proliferation-1 type B1; mature T-cell proliferation 1 isoform p13;
NEDD4L
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
NEDD4L; neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase; neural precursor cell expressed, developmentally down regulated 4 like; E3 ubiquitin-protein ligase NEDD4-like; KIAA0439; NEDD4 2; RSP5; ubiquitin;
NME6
non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase)
NME6; non-metastatic cells 6, protein expressed in (nucleoside-diphosphate kinase); nucleoside diphosphate kinase 6; IPIA ALPHA; NM23 H6; NDP kinase 6; inhibitor of p53-induced apoptosis-alpha; NDK 6; NM23-H6; IPIA-ALPHA;
PCP4
Purkinje cell protein 4
PCP4;Purkinje cell protein 4;PEP 19;brain-specific antigen PCP-4;brain specific polypeptide PEP19;brain-specific polypeptide PEP-19;PEP-19;
PDCD10
programmed cell death 10
PDCD10; programmed cell death 10; CCM3, cerebral cavernous malformations 3; programmed cell death protein 10; TFAR15; apoptosis-related protein 15; TF-1 cell apoptosis-related protein 15; cerebral cavernous malformations 3 protein; CCM3; MGC1212; MGC2447;
RBP2
retinol binding protein 2, cellular
RBP2; retinol binding protein 2, cellular; retinol-binding protein 2; CRABP II; CRBP2; CRBPII; RBPC2; MGC159254; MGC159256; Retinol binding protein 2 cellular; Cellular retinol binding protein II; Cellular retinol-binding protein II; Crbp 2; CRBP II; CRBP-II; Rbp 2; RET2_HUMAN; Retinol binding protein 2; retinol-binding protein 2, cellular; CRABP-II;
SWAP70
SWAP switching B-cell complex 70kDa subunit
SWAP70; SWAP switching B-cell complex 70kDa subunit; switch-associated protein 70; KIAA0640; SWAP 70; HSPC321; SWAP-70; FLJ39540;
TAL2
T-cell acute lymphocytic leukemia 2
TAL2; T-cell acute lymphocytic leukemia 2; T-cell acute lymphocytic leukemia protein 2; bHLHa19; Class A basic helix-loop-helix protein 19; T cell acute lymphocytic leukemia 2; T cell acute lymphocytic leukemia protein 2; TAL 2; TAL-2; TAL2_HUMAN; OTTHUMP00000021840;
TCF7
transcription factor 7 (T-cell specific, HMG-box)
TCF7; transcription factor 7 (T-cell specific, HMG-box); transcription factor 7; TCF 1; T-cell-specific transcription factor 1; TCF-1; FLJ36364; MGC47735;
TCIRG1
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
TCIRG1; T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3; T cell, immune regulator 1 , T cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein a isoform 3 , T cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3; V-type proton ATPase 116 kDa subunit a isoform 3; a3; Atp6i; ATP6N1C; ATP6V0A3; OC 116; OC116; T cell immune response cDNA 7; TIRC7; Atp 6i; ATPase H+ transporting 116kD; OC 116 kDa; OC 116kDa; OPTB 1; OPTB1; Osteoclastic proton pump 116 kDa subunit; Specific 116 kDa vacuolar proton pump subunit; Stv 1; Stv1; T cell immune regulator 1; T cell immune regulator 1 ATPase H+ transporting lysosomal V0 subunit A; T cell immune regulator 1 ATPase H+ transporting lysosomal V0 subunit A3; T cell immune response cDNA7 protein; TCIRG 1; TIRC 7; V ATPase 116 kDa; V ATPase 116 kDa isoform a3; Vacuolar proton translocating ATPase 116 kDa subunit A; Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3; Vph 1; Vph1; OC-116 kDa; V-ATPase 116-kDa; OTTHUMP00000235794; OTTHUMP00000235863; T-cell immune response cDNA 7; ATPase, H+ transporting, 116kD; V-type proton ATPase 116 kDa subunit a; OC-116kDa;
TRAT1
T cell receptor associated transmembrane adaptor 1
TRAT1; T cell receptor associated transmembrane adaptor 1; TRIM; TCRIM; HSPC062; T-cell receptor-associated transmembrane adapter 1; pp29/30; T cell receptor interacting molecule; T-cell receptor interacting molecule; T-cell receptor-interacting molecule;
XRCC2
X-ray repair complementing defective repair in Chinese hamster cells 2
XRCC2; X-ray repair complementing defective repair in Chinese hamster cells 2; DNA repair protein XRCC2; RAD51 like; X-ray repair cross-complementing protein 2; X-ray repair, complementing defective, repair in Chinese hamster; DKFZp781P0919;
GSG2
germ cell associated 2 (haspin)
GSG2; germ cell associated 2 (haspin); HASPIN; serine/threonine-protein kinase haspin; H-haspin; germ cell-specific gene 2 protein; haploid germ cell-specific nuclear protein kinase;
ICK
intestinal cell (MAK-like) kinase
ICK; intestinal cell (MAK-like) kinase; serine/threonine-protein kinase ICK; KIAA0936; LCK2; MGC46090; MRK; hICK; MAK-related kinase; laryngeal cancer kinase 2; serine/threonine protein kinase; ECO;
BCL9L
B-cell CLL/lymphoma 9-like
BCL9L; B-cell CLL/lymphoma 9-like; B-cell CLL/lymphoma 9-like protein; DLNB11; B-cell CLL; B-cell lymphoma 9-like protein; B9L; BCL9-2; BCL9-like protein; BCL9-related beta-catenin-binding protein; BCL9L_HUMAN; Nuclear co factor of beta catenin signalling; Protein BCL9-2; nuclear co-factor of beta-catenin signalling;
CDC20B
cell division cycle 20 homolog B (S. cerevisiae)
CDC20B; cell division cycle 20 homolog B (S. cerevisiae); CDC20 cell division cycle 20 homolog B (S. cerevisiae); cell division cycle protein 20 homolog B; FLJ37927; CDC20 cell division cycle 20 homolog B; CDC20 like protein; CDC20B protein; cell division cycle 20 homolog B (S cerevisiae); G6VTS76519; CDC20-like protein;
CGRRF1
cell growth regulator with ring finger domain 1
CGRRF1; cell growth regulator with ring finger domain 1; cell growth regulator with RING finger domain protein 1; CGR19; RNF197; Cell growth regulatory gene 19 protein; Cell Growth Regulatory with Ring Finger Domain; CGRRF 1; RING finger protein 197;
KIR3DX1
killer cell immunoglobulin-like receptor, three domains, X1
killer cell immunoglobulin-like receptor, three domains, X1; FLJ00060; KIR3DL0; LENG12; leukocyte receptor cluster (LRC) member 12; Leukocyte receptor cluster member 12; KIR3DX1;
MCTS1
malignant T cell amplified sequence 1
MCTS1; malignant T cell amplified sequence 1; malignant T cell-amplified sequence 1; MCT 1; FLJ39637; MCT-1; MCT1; MCTS 1; MCTS1_HUMAN; Multiple copies T cell malignancies 1; Multiple copies T cell malignancies; Multiple copies T-cell malignancies; Oncogene MCT 1; Oncogene MCT1;
NME5
non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase)
NME5; non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase); nucleoside diphosphate kinase homolog 5; nm23 H5; radial spoke 23 homolog (Chlamydomonas); RSPH23; NDK-H 5; IPIA-beta; NDP kinase homolog 5; radial spoke 23 homolog; testi;
NME7
non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase)
NME7; non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase); nucleoside diphosphate kinase 7; FLJ37194; NM23 H7; NDK 7; NDP kinase 7; nucleoside-diphosphate kinase 7; MN23H7; nm23-H7;
SPON2
spondin 2, extracellular matrix protein
SPON2; spondin 2, extracellular matrix protein; spondin-2; DIL1; M spondin; Mindin; SPON 2; Differentially expressed in cancerous and non-cancerous lung cells 1; DIL 1; DKFZp686G21139; FLJ16313; FLJ22401; FLJ34460; Spondin 2; DIL-1; M-SPONDIN;
TRBV5-3
T cell receptor beta variable 5-3 (non-functional)
T cell receptor beta variable 5-3 (non-functional); TCRBV5S3; TCRBV5S5P; TRBV53; T cell receptor beta variable 5-3; TRBV5-3;
BCL11B
B-cell CLL/lymphoma 11B (zinc finger protein)
BCL11B; B-cell CLL/lymphoma 11B (zinc finger protein); ATL1; RIT1; CTIP2; CTIP-2; ZNF856B; ATL1-beta; ATL1-alpha; ATL1-delta; ATL1-gamma; hRIT1-alpha; B-cell lymphoma/leukemia 11B; hRit1; BCL-11B; BCL11B/TRDC fusion; B-cell lymphoma/leukaemia 11B; COUP-TF-interacting protein 2; zinc finger protein hRit1 alpha; radiation-induced tumor suppressor gene 1 protein; B-cell CLL/lymphoma 11B/T-cell receptor delta constant region fusion protein;
BTG1
B-cell translocation gene 1, anti-proliferative
BTG1; B-cell translocation gene 1, anti-proliferative; protein BTG1; B-cell translocation gene 1 protein;
CDC20
cell division cycle 20 homolog (S. cerevisiae)
CDC20; cell division cycle 20 homolog (S. cerevisiae); CDC20A; p55CDC; MGC102824; bA276H19.3; cell division cycle protein 20 homolog; OTTHUMP00000008571; OTTHUMP00000008572; CDC20 cell division cycle 20 homolog; Cdc 20; fizzy;
CEACAM19
carcinoembryonic antigen-related cell adhesion molecule 19
CEACAM19; carcinoembryonic antigen-related cell adhesion molecule 19; CEAL1; Carcinoembryonic antigen like 1; Carcinoembryonic antigen related cell adhesion molecule 19; CEA related cell adhesion molecule 19; MGC105097; OTTHUMP00000200169; OTTHUMP00000200170; carcinoembryonic antigen-like 1;
CEACAM20
carcinoembryonic antigen-related cell adhesion molecule 20
CEACAM20; carcinoembryonic antigen-related cell adhesion molecule 20; UNQ9366; carcinoembryonic antigen related cell adhesion molecule 20; GPAD9366;
CEACAM7
carcinoembryonic antigen-related cell adhesion molecule 7
CEACAM7; carcinoembryonic antigen-related cell adhesion molecule 7; CGM2; carcinoembryonic antigen gene family member 2; CEA; Carcinoembryonic antigen CGM 2; Carcinoembryonic antigen CGM2; Carcinoembryonic antigen related cell adhesion molecule 7; CEACAM 7; CGM 2; OTTHUMP00000199040; OTTHUMP00000199041;
CEV1
cellulose synthase A catalytic subunit 3 [UDP-forming]
CEV1; cellulose synthase A catalytic subunit 3 [UDP-forming]; ATCESA3; ATH B; ATHB; AtRSW5; Cellulose synthase 3; Cellulose synthase A catalytic subunit 3 [UDP forming]; Cellulose synthase A catalytic subunit 3; Cellulose synthase/ transferase transferring glycosyl groups; Constitutive expression of VSP1; Constitutive expression of VSP1 protein 1; ELI1; Isoxaben resistant 1; Isoxaben resistant protein 1; IXR1; K2A11.4; K2A11_4; Protein ECTOPIC LIGNIN 1; Protein RADIALLY SWOLLEN 5; RSW5; Cellulose synthase family protein CONSTITUTIVE EXPRESSION OF VSP 1 (CEV1); FUNCTIONS IN: cellulose synthase activity, transferase activity, transferring glycosyl groups; INVOLVED IN: primary cell wall biogenesis, cellulose biosynthetic process, defense re; ATH-B; CESA3; CONSTITUTIVE EXPRESSION OF VSP 1;
EFEMP1
EGF containing fibulin-like extracellular matrix protein 1
EFEMP1; EGF containing fibulin-like extracellular matrix protein 1; DHRD; DRAD; FBNL; MLVT; MTLV; S1-5; FBLN3; FIBL-3; EGF-containing fibulin-like extracellular matrix protein 1; fibulin-3; extracellular protein S1-5;
FRAT1
frequently rearranged in advanced T-cell lymphomas
FRAT1; frequently rearranged in advanced T-cell lymphomas; proto-oncogene FRAT1; FRAT-1; frequently rearranged in advanced T-cell lymphomas 1; FLJ97193;
HCFC2
host cell factor C2
HCFC2; host cell factor C2; host cell factor 2; HCF 2; C2 factor; HCF2; HCF-2; FLJ94012;
KLRA6
killer cell lectin-like receptor, subfamily A, member 6
KLRA6; killer cell lectin-like receptor, subfamily A, member 6; killer cell lectin-like receptor 6; ly-49f; lymphocyte antigen 49f; T-cell surface glycoprotein Ly-49F; Ly49f;
KLRA9
killer cell lectin-like receptor subfamily A, member 9
KLRA9; killer cell lectin-like receptor subfamily A, member 9; Killer cell lectin like receptor subfamily A member 9; Ly49I receptor; LY49I1; OTTMUSP00000026553; OTTMUSP00000026554; Ly49I;
KLRB1C
killer cell lectin-like receptor subfamily B member 1C
KLRB1C; killer cell lectin-like receptor subfamily B member 1C; NKR-P1 40; lymphocyte antigen 59; lymphocyte antigen 55c; natural killer cell receptor-P1; CD161 antigen-like family member C; lymphocyte antigen 55 complex, locus C; natural killer cell-asso;
KLRF1
killer cell lectin-like receptor subfamily F, member 1
KLRF1; killer cell lectin-like receptor subfamily F, member 1; killer cell lectin-like receptor subfamily F member 1; CLEC5C; NKp80; Activating coreceptor NKp80; C type lectin domain family 5 member C; killer cell lectin like receptor F1; Killer cell lectin like receptor subfamily F member 1; KLRF 1; Lectin like receptor F1; MGC119907; MGC119908; MGC119909; ML; OTTHUMP00000238675; OTTHUMP00000238676; OTTHUMP00000238678; lectin-like receptor F1; killer cell lectin-like receptor F1; C-type lectin domain family 5 member C;
KLRG1
killer cell lectin-like receptor subfamily G, member 1
KLRG1; killer cell lectin-like receptor subfamily G, member 1; killer cell lectin-like receptor subfamily G member 1; mast cell function-associated antigen 2F1; MAFA; 2F1-Ag; MAFA-L; MGC123930;
KLRK1
Klrk1 killer cell lectin-like receptor subfamily K, member 1
KLRK1; killer cell lectin-like receptor subfamily K, member 1; NKG2-D type II integral membrane protein; NK cell receptor D; natural killer cell group 2D; NKG2-D-activating NK receptor; Nkg2d; NKG2-D; D6H12S2489E;
MCF2L2
MCF.2 cell line derived transforming sequence-like 2
MCF2L2; MCF.2 cell line derived transforming sequence-like 2; probable guanine nucleotide exchange factor MCF2L2; ARHGEF22; KIAA0861; MCF2-transforming sequence-like protein 2; dbs-related Rho family guanine nucleotide exchange factor; FLJ42509; DKFZp686H;
NET1
neuroepithelial cell transforming 1
NET1; neuroepithelial cell transforming 1; neuroepithelial cell-transforming gene 1 protein; ARHGEF8; NET1A; proto-oncogene p65 Net1; p65 Net1 proto-oncogene protein; small GTP-binding protein regulator; neuroepithelioma transforming gene 1; neuroepitheli;
PRG2
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
PRG2; proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein); MBP; BMPG; MBP1; bone marrow proteoglycan; bone-marrow proteoglycan; proteoglycan 2 preproprotein; natural killer cell activator; eosinophil major basic protein; eosinophil granule major basic protein; prg-2; Piwi (fruitfly) Related Gene; Piwi (fruitfly) Related Gene family member (prg-2); 4H292; tag-292;
TIMD2
T-cell immunoglobulin and mucin domain containing 2
TIMD2; T-cell immunoglobulin and mucin domain containing 2; T-cell immunoglobulin and mucin domain-containing protein 2; T cell immunoglobulin and mucin domain containing 2 protein; Tim2; TIMD-2; OTTMUSP00000005656; OTTMUSP00000005657; T-cell membrane protein 2; G9D3; TIM-2; C78111; AA816106; AU019358; AU019662;
CDC26
cell division cycle 26 homolog
CDC26; cell division cycle 26 homolog (S. cerevisiae); C9orf17, cell division cycle 26 , chromosome 9 open reading frame 17; anaphase-promoting complex subunit CDC26; ANAPC12; anaphase promoting complex subunit 12; APC12; CDC26 subunit of anaphase promo;
HCFC1
host cell factor C1 (VP16-accessory protein)
HCFC1; host cell factor C1 (VP16-accessory protein); HFC1; host cell factor 1; CFF; HCF 1; HCF1; MGC70925; VCAF; HCF; C1 factor; VP16 accessory protein; HCF-1;
LECT1
leukocyte cell derived chemotaxin 1
LECT1; leukocyte cell derived chemotaxin 1; multiple myeloma tumor suppressor 1 , MYETS1; leukocyte cell-derived chemotaxin 1; CHM I; CHM1; chondromodulin; Chondromodulin I; BRICD3; BRICHOS domain containing 3; Chondrosurfactant protein; LECT 1; chondromodulin-1; chondromodulin-I; OTTHUMP00000018466; OTTHUMP00000235443; multiple myeloma tumor suppressor 1; CHM-I; MYETS1;
MKLN1
muskelin 1, intracellular mediator containing kelch motifs
MKLN1; muskelin 1, intracellular mediator containing kelch motifs; muskelin; TWA2; MKLN 1; OTTHUMP00000206857; OTTHUMP00000207137;
BCL7A
B-cell CLL/lymphoma 7A
BCL7A; B-cell CLL/lymphoma 7A; BCL7; B-cell CLL/lymphoma 7 protein family member A; B-cell CLL/lymphoma-7;
CCAR1
cell division cycle and apoptosis regulator 1
CCAR1; cell division cycle and apoptosis regulator 1; cell division cycle and apoptosis regulator protein 1; CARP 1; CARP1; FLJ10590; death inducer with SAP domain; cell cycle and apoptosis regulatory protein 1; MGC44628; RP11-437A18.1;
CDC16
cell division cycle 16 homolog (S. cerevisiae)
CDC16; cell division cycle 16 homolog (S. cerevisiae); CDC16 (cell division cycle 16, S. cerevisiae, homolog) , CDC16 cell division cycle 16 homolog (S. cerevisiae); cell division cycle protein 16 homolog; ANAPC6; anaphase promoting complex; subunit 6; APC6; CUT9; Anaphase promoting complex subunit 6; Anaphase-promoting complex subunit 6; Apc 6; CDC 16; CDC16 (cell division cycle 16 S. cerevisiae homolog); CDC16 homolog; CDC16 protein; CDC16_HUMAN; CDC16Hs; Cell division cycle 16 homolog; Cyclosome subunit 6; anaphase-promoting complex, subunit 6;
ELMO1
engulfment and cell motility 1
ELMO1; engulfment and cell motility 1; CED12; CED-12; ELMO-1; engulfment and cell motility protein 1; ced-12 homolog 1;
ELMO3
engulfment and cell motility 3
ELMO3; engulfment and cell motility 3; engulfment and cell motility 3 (ced 12 homolog, C. elegans); engulfment and cell motility protein 3; CED 12; CED12; ELMO 3; FLJ13824; ced-12 homolog 3; CED-12; ELMO-3;
FLVCR2
feline leukemia virus subgroup C cellular receptor family, member 2
FLVCR2; feline leukemia virus subgroup C cellular receptor family, member 2; C14orf58, chromosome 14 open reading frame 58 , feline leukemia virus subgroup C cellular receptor 2; feline leukemia virus subgroup C receptor-related protein 2; FLJ20371; MFS;
Klrb1a
killer cell lectin-like receptor subfamily B member 1A
KLRB1A;killer cell lectin-like receptor subfamily B member 1A;Nkrp1a;
MUC17
mucin 17, cell surface associated
MUC17; mucin 17, cell surface associated; mucin-17; MUC-3; MUC-17; membrane mucin MUC17; secreted mucin MUC17; small intestinal mucin-3; small intestinal mucin MUC3; MUC3;
BCL6B
B-cell CLL/lymphoma 6, member B
BCL6B; B-cell CLL/lymphoma 6, member B; B cell CLL/lymphoma 6, member B (zinc finger protein) , zinc finger protein 62 , ZNF62; B-cell CLL/lymphoma 6 member B protein; BAZF; ZBTB28; B cell CLL/lymphoma 6, member B (zinc finger protein); B-cell CLL/lymphoma 6, member B (zinc finger protein); Bcl6 associated zinc finger protein; Bcl6-associated zinc finger protein; Zinc finger protein 62; ZNF62;
BANK1
B-cell scaffold protein with ankyrin repeats 1
BANK1; B-cell scaffold protein with ankyrin repeats 1; B-cell scaffold protein with ankyrin repeats; BANK; FLJ20706; FLJ34204;
ICA1L
islet cell autoantigen 1,69kDa-like
ICA1L; islet cell autoantigen 1,69kDa-like; ALS2CR14, ALS2CR15, amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 14 , amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 15; islet cell autoantigen 1-like protein; ALS2CR14; ALS2CR15 protein; Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 15 protein; amyotrophic lateral sclerosis 2 juvenile chromosome region candidate 14; amyotrophic lateral sclerosis 2 juvenile chromosome region candidate 15; DKFZp434E1919; Hypothetical protein DKFZp434E1919; Ica69 related protein; Ica69-related protein; islet cell autoantigen 1 69kDa-like; LOC130026; MGC138440; amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 14; amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 15; amyotrophic lateral sclerosis 2 chromosomal region candidate gene 14 protein; ALS2CR15;
BOD1
biorientation of chromosomes in cell division 1
BOD1; biorientation of chromosomes in cell division 1; FAM44B, family with sequence similarity 44, member B; biorientation of chromosomes in cell division protein 1; biorientation defective 1; family with sequence similarity 44, member B; FAM44B;
CLNK
cytokine-dependent hematopoietic cell linker
CLNK; cytokine-dependent hematopoietic cell linker; mast cell immunoreceptor signal transducer; MIST; MGC35197;
CEACAM4
carcinoembryonic antigen-related cell adhesion molecule 4
CEACAM4; carcinoembryonic antigen-related cell adhesion molecule 4; CGM7; carcinoembryonic antigen CGM7; nonspecific cross-reacting antigen W236; Nonspecific cross-reacting antigen (NCA); non-specific cross-reacting antigen W236; carcinoembryonic antigen;
CERCAM
cerebral endothelial cell adhesion molecule
CERCAM; cerebral endothelial cell adhesion molecule; CEECAM1, cerebral cell adhesion molecule; glycosyltransferase 25 family member 3; GLT25D3; glycosyltransferase 25 domain containing 3; CEECAM1; Cerebral endothelial cell adhesion molecule 1; Glycosyltransferase 25 family member 3 precursor; cerebral cell adhesion molecule;
CEACAM21
carcinoembryonic antigen-related cell adhesion molecule 21
CEACAM21; carcinoembryonic antigen-related cell adhesion molecule 21; FLJ13540; R29124_1; Carcinoembryonic antigen related cell adhesion molecule 21; CEA21_HUMAN; CEACAM3; MGC119874; OTTHUMP00000199036;
CDCA5
cell division cycle associated 5
CDCA5; cell division cycle associated 5; sororin; Cell division cycle associated protein 5; MGC16386; p35; cell division cycle-associated protein 5;
CDCA2
cell division cycle associated 2
CDCA2; cell division cycle associated 2; Repo-Man; cell division cycle-associated protein 2; recruits PP1 onto mitotic chromatin at anaphase protein; protein phosphatase 1 [gamma] (PPP1R3A) binding protein Repo-Man;
CDC14B
CDC14 cell division cycle 14 homolog B (S. cerevisiae)
CDC14B; CDC14 cell division cycle 14 homolog B (S. cerevisiae); dual specificity protein phosphatase CDC14B; Cdc 14B; Cdc 14B1; Cdc 14B2; CDC 14B3; CDC14 cell division cycle 14 homolog B; CDC14 homolog B; Cdc14B1; Cdc14B2; CDC14B3; Cell division cycle 14 homolog B; hCDC 14B; hCDC14B; OTTHUMP00000063774;
CDC27
CDC27 cell division cycle 27 homolog (S. cerevisiae)
CDC27; cell division cycle 27 homolog (S. cerevisiae); APC3; HNUC; NUC2; ANAPC3; CDC27Hs; D0S1430E; D17S978E; cell division cycle protein 27 homolog; H-NUC; nuc2 homolog; CDC27 homolog; OTTHUMP00000232872; OTTHUMP00000232873; OTTHUMP00000232875; OTTHUMP00000232877; anaphase promoting complex subunit 3; anaphase-promoting complex subunit 3; anaphase-promoting complex, protein 3;
CDCA7L
cell division cycle associated 7-like
CDCA7L; cell division cycle associated 7-like; cell division cycle-associated 7-like protein; JPO2; R1; RAM2; transcription factor RAM2; DKFZp762L0311;
CESA1
cellulose synthase A catalytic subunit 1 [UDP-forming]
CESA1; cellulose synthase A catalytic subunit 1 [UDP-forming]; F8B4_110; RSW1; Cellulose synthase 1; F8B4.110; Radially Swollen 1; cellulose synthase 1 (CESA1); FUNCTIONS IN: cellulose synthase activity, transferase activity, transferring glycosyl groups; INVOLVED IN: primary cell wall biogenesis, cellulose biosynthetic process, plant-type cell wall biogenesis, hyperosmotic salinity response; LOCATED IN: Golgi apparatus, plasma membrane; EXPRESSED IN: 26 plant structures; EXPRESSED DURING: 16 growth stages; CONTAINS InterPro DOMAIN/s: Cellulose synthase (InterPro:IPR005150), Zinc finger, RING-type (InterPro:IPR001841); BEST Arabidopsis thaliana protein match is: cellulose synthase 10 (TAIR:AT2G25540.1); Has 1807 Blast hits to 1807 proteins in 277 species: Archae - 0; Bacteria - 0; Metazoa - 736; Fungi - 347; Plants - 385; Viruses - 0; Other Eukaryotes - 339 (source: NCBI BLink).; AtCESA1;
CWF19L2
CWF19-like 2, cell cycle control
CWF19L2; CWF19-like 2, cell cycle control (S. pombe); CWF19-like protein 2; FLJ32343;
CWH43
cell wall biogenesis 43 C-terminal homolog (S. cerevisiae)
CWH43; cell wall biogenesis 43 C-terminal homolog (S. cerevisiae); PGAP2-interacting protein; CWH43 C; FLJ21511; C130090K23Rik; Cell wall biogenesis protein 43 C-terminal homolog; imds 60; PG2IP_HUMAN; CWH43-C;
ECT2
epithelial cell transforming sequence 2 oncogene
ECT2; epithelial cell transforming sequence 2 oncogene; protein ECT2; ARHGEF31; ECT 2; ECT2 protein; Epithelial Cell Transforming Sequence 2; Epithelial cell transforming sequence 2 oncogene protein; FLJ10461; MGC138291; OTTHUMP00000210539; OTTHUMP00000210684; OTTHUMP00000210685; OTTHUMP00000210686; epithelial cell-transforming sequence 2 oncogene;
ERAS
ES cell expressed Ras
ERAS; ES cell expressed Ras; HRAS2, HRASP, v Ha ras Harvey rat sarcoma viral oncogene homolog pseudogene; GTPase ERas; E-Ras; small GTPase protein E-Ras; embryonic stem cell-expressed Ras; v-Ha-ras Harvey rat sarcoma viral oncogene homolog 2; v-Ha-ras Ha;
FREM2
FRAS1 related extracellular matrix protein 2
FREM2; FRAS1 related extracellular matrix protein 2; FRAS1-related extracellular matrix protein 2; ECM3 homolog;
GCM2
glial cells missing homolog 2 (Drosophila)
GCM2; glial cells missing homolog 2 (Drosophila); chorion-specific transcription factor GCMb;
FRAT2
frequently rearranged in advanced T-cell lymphomas 2
FRAT2; frequently rearranged in advanced T-cell lymphomas 2; GSK-3-binding protein FRAT2; GSK 3 binding protein FRAT2; GSK-3 binding protein FRAT2; FRAT-2;
FREM1
FRAS1 related extracellular matrix 1
FREM1; FRAS1 related extracellular matrix 1; C9orf154, chromosome 9 open reading frame 154; FRAS1-related extracellular matrix protein 1; C9orf143; C9orf145; DKFZp686M16108; FLJ25461; TILRR; BC037594; D630008K06; MOTA; BNAR; C9orf154; D430009N09; FREM 1; FREM1_HUMAN; Heb; Protein QBRICK; QBRICK; RGD1306981; RP11-265B7.2; RP23-410K19.1; extracellular matrix protein QBRICK;
GSG1
germ cell associated 1
GSG1; germ cell associated 1; germ cell-specific gene 1 protein; MGC3146; MGC111023;
CAPRIN1
cell cycle associated protein 1
CAPRIN1; cell cycle associated protein 1; GPI anchored membrane protein 1 , GPIAP1, M11S1, membrane component, chromosome 11, surface marker 1; caprin-1; caprin 1; cytoplasmic activation/proliferation associated protein 1; RNG105; GPI-p137; RNA granule p;
HCST
hematopoietic cell signal transducer
HCST; hematopoietic cell signal transducer; phosphoinositide 3 kinase adaptor protein , PIK3AP; DAP10; DKFZP586C1522; DNAX activation protein 10; KAP10; kinase assoc pro of ~10kDa; Membrane protein DAP10; phosphoinositide 3 kinase adaptor protein; PIK3AP; Transmembrane adapter protein KAP10; kinase assoc protein; DNAX-activation protein 10; phosphoinositide-3-kinase adaptor protein;
HEPACAM
hepatic and glial cell adhesion molecule
HEPACAM; hepatic and glial cell adhesion molecule; hepatocyte cell adhesion molecule; FLJ25530; glial cell adhesion molecule; GLIALCAM; protein hepaCAM; MLC2A; MLC2B;
KIR2DS1
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
KIR2DS1; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1; killer cell immunoglobulin-like receptor 2DS1; CD158H; EB6ActI; EB6ActII; p50.1; CD158 antigen-like family member H; CD158a; KI2S1_HUMAN; MHC class I NK cell receptor Eb6 ActI; XXbac-BCX195L8.7; KIR2DL1-KIR2DS1; killer-cell immunoglobulin-like receptor; killer cell immunoglobulin-like receptor KIRDS1;
CDC73
cell division cycle 73, Paf1/RNA polymerase II complex component, homolog
CDC73; cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae); C1orf28, chromosome 1 open reading frame 28 , HRPT2, hyperparathyroidism 2 (with jaw tumor); parafibromin; hyperparathyroidism 2 protein; cell division cyc;
HCFC1R1
host cell factor C1 regulator 1 (XPO1 dependent)
HCFC1R1; host cell factor C1 regulator 1 (XPO1 dependent); host cell factor C1 regulator 1 (XPO1 dependant); host cell factor C1 regulator 1; FLJ20568; HPIP; HCF 1 beta propeller interacting protein; HCF-1 beta-propeller-interacting protein; HCF1 beta propeller interacting protein; HPIP_HUMAN; Inhibitor of four 2; HCF-1 beta-propeller interacting protein;
INSL3
insulin-like 3 (Leydig cell)
INSL3; insulin-like 3 (Leydig cell); relaxin like factor , RLNL; insulin-like 3; MGC119818; MGC119819; RLF; ley-I-L; relaxin-like factor b; leydig insulin-like peptide; leydig insulin -like hormone; leydig insulin -like peptide; RLNL;
ICAM4
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)
ICAM4; intercellular adhesion molecule 4 (Landsteiner-Wiener blood group); intercellular adhesion molecule 4 (LW blood group) , intercellular adhesion molecule 4, Landsteiner Wiener blood group , Landsteiner Wiener blood group , LW; intercellular adhesion molecule 4; CD242; CD242 antigen; ICAM-4; ICAM4_HUMAN; Landsteiner Wiener blood group glycoprotein; Landsteiner-Wiener blood group glycoprotein; LW; LW blood group protein; Landsteiner-Wiener blood group antigen a; intercellular adhesion molecule 4 (LW blood group);
MAL2
mal, T-cell differentiation protein 2
MAL2; mal, T-cell differentiation protein 2; protein MAL2; MAL 2; MAL proteolipid protein 2; Mal, T cell differentiation protein 2; MAL2_HUMAN; AI461653;
MALL
mal, T-cell differentiation protein-like
MALL; mal, T-cell differentiation protein-like; MAL-like protein; BENE; MAL like protein; mal T cell differentiation protein like; Protein BENE;
LIMS2
LIM and senescent cell antigen-like domains 2
LIMS2; LIM and senescent cell antigen-like domains 2; LIM and senescent cell antigen-like-containing domain protein 2; FLJ10044; LIM-like protein 2; LIMS2_HUMAN; Particularly interesting new Cys-His protein 2; PINCH-2; ILK-binding protein; PINCH2;
KLRA3
killer cell lectin-like receptor, subfamily A, member 3
KLRA3; killer cell lectin-like receptor, subfamily A, member 3; killer cell lectin-like receptor 3; lymphocyte antigen 49c; T-cell surface glycoprotein Ly-49C; natural killer cell-associated antigen 2; 5E6; Nk2; Nk-2; Ly49c; Nk2.1; NK-2.1; MGC123910;
KIR2DS2
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
KIR2DL+KIR2DS1+KIR2DS2; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2; KIR2DS2; killer cell immunoglobulin-like receptor 2DS2; 183ActI; CD158J; cl 49; nkat5; NKAT-5; p58 KIR; 1060P11.9.2; NK receptor 183 ActI; p58 NK receptor CL-49; MHC class I;
KIR2DS5
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
KIR2DS5; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5; killer cell immunoglobulin-like receptor 2DS5; CD158G; nkat9; CD158 antigen like family member G; Flags: Precursor; Killer cell immunoglobulin like receptor 2DS5; Killer cell immunoglobulin like receptor two domains short cytoplasmic tail 5; MHC class I NK cell receptor; Natural killer associated transcript 9; Natural killer cell inhibitory receptor; NKAT 9; NKAT-9; CD158 antigen-like family member G; natural killer-associated transcript 9;
KIR3DL2
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
KIR3DL2; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2; killer cell immunoglobulin-like receptor 3DL2; CD158K; cl 5; nkat4; nkat4a; nkat4b; CD158 antigen like family member K; CD158 antigen-like family member K; KI3L2_HUMAN; Killer cell immunoglobulin like receptor 3DL2; killer cell immunoglobulin like receptor KIR3DL2; Killer cell immunoglobulin like receptor, three domains, long cytoplasmic tail, 2; KIR antigen 3DL2; Kirl2; MHC class I NK cell receptor; Natural killer associated transcript 4; natural killer cell inhibitory receptor; Natural killer-associated transcript 4; NK associated transcript 4; NK associated transcript 4A, included; NK associated transcript 4B, included; NKAT-4; p140; p70 natural killer cell receptor clone CL 5; p70 natural killer cell receptor clone CL-5; p70 NK receptor CL 5; p70 NK receptor CL-5; killer Ig receptor; p70 killer cell inhibitory receptor; killer cell immunoglobulin-like receptor KIR3DL2;
KLRA2
killer cell lectin-like receptor, subfamily A, member 2
KLRA2; killer cell lectin-like receptor, subfamily A, member 2; killer cell lectin-like receptor 2; Ly49-b; Ly-49b; Ly49b; Lymphocyte antigen 49b; T-cell surface glycoprotein Ly-49B; membrane protein Ly49b; NK cell inhibitory receptor Klra2; T-cell surface glycoprotein Ly49b; killer cell lectin-like receptor subfamily A member 30; Klra30;
LOC727787
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like
LOC727787; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like; Killer cell immunoglobulin like receptor three domains long cytoplasmic tail 2 like; LOC727787|-|-;
NCAM2
neural cell adhesion molecule 2
NCAM2; neural cell adhesion molecule 2; MGC51008; N CAM 2; N CAM 21; N CAM2; N CAM21; N-CAM-2; NCAM 2; NCAM 21; NCAM-2; NCAM2_HUMAN; NCAM21; OCAM GPI; R4B12; RB 8 neural cell adhesion molecule; RB8 neural cell adhesion molecule; RNCAM; R4B12 antigen; neural cell adhesion molecule RB-8; olfactory axon cell adhesion molecule; Ocam;
MCF2
MCF.2 cell line derived transforming sequence
MCF2; MCF.2 cell line derived transforming sequence; proto-oncogene DBL; ARHGEF21; DBL; Oncogene MCF2 (oncogene DBL); DBL-transforming protein; MCF2-transforming protein; Proto-oncogene MCF-2;
WDPCP
WD repeat containing planar cell polarity effector
WDPCP; WD repeat containing planar cell polarity effector; C2orf86, chromosome 2 open reading frame 86; WD repeat-containing and planar cell polarity effector protein fritz homolog; BBS15; fritz; hFrtz; Bardet-Biedl syndrome 15 protein; Chromosome 2 open reading frame 86; DKFZp686C12204; FRITZ_HUMAN; WD repeat containing protein C2orf86; WD repeat-containing and planar cell polarity effector protein; OTTHUMP00000201980; OTTHUMP00000201983; WD repeat-containing protein C2orf86; FRTZ; C2orf86;
NCCRP1
non-specific cytotoxic cell receptor protein 1 homolog (zebrafish)
NCCRP1; non-specific cytotoxic cell receptor protein 1 homolog (zebrafish); non-specific cytotoxic cell receptor protein 1 homolog; FBXO50; LOC342897; NCCRP 1; Gm163; NCRP1_HUMAN; Non specific cytotoxic cell receptor protein 1 homolog (zebrafish); Non specific cytotoxic cell receptor protein 1 homolog; Nonspecific cytotoxic cell receptor protein 1 homolog; RGD1305932; NCCRP-1;
PRCC
papillary renal cell carcinoma (translocation-associated)
PRCC; papillary renal cell carcinoma (translocation-associated); proline-rich protein PRCC; RCCP1; papillary renal cell carcinoma translocation-associated gene protein; TPRC; MGC4723; MGC17178;
METRN
meteorin, glial cell differentiation regulator
METRN; meteorin, glial cell differentiation regulator; C16orf23, chromosome 16 open reading frame 23; meteorin; MGC2601; Meteorin precursor; METRN_HUMAN; C16orf23; c380A1.2;
MCPT4
mast cell protease 4
MCPT4; mast cell protease 4; Mcp 4; MMCP 4; MMCP 4A; MMCP 4B; MMCP4; MMCP4A; MMCP4B; MSMCP; Myonase; Serosal mast cell protease; Mcp4; Mcp-4; MMCP-4; MMCP-4A; MMCP-4B;
PBXIP1
pre-B-cell leukemia homeobox interacting protein 1
PBXIP1; pre-B-cell leukemia homeobox interacting protein 1; pre B cell leukemia transcription factor interacting protein 1; pre-B-cell leukemia transcription factor-interacting protein 1; HPIP; 4732463H20Rik; MGC38361; Hematopoietic PBX interacting protein; Pre B cell leukemia homeobox interacting protein 1; RP11-307C12.2; OTTHUMP00000035484; OTTHUMP00000035485; OTTHUMP00000035486; OTTHUMP00000035487; hematopoietic PBX-interacting protein; pre-B-cell leukemia transcription factor interacting protein 1;
MEPE
matrix extracellular phosphoglycoprotein
MEPE; matrix extracellular phosphoglycoprotein; matrix, extracellular phosphoglycoprotein with ASARM motif (bone); osteoblast/osteocyte factor 45; OF45;
NFKBIL1
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
NFKBIL1; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1; IKBL; LST1; NFKBIL; NF-kappa-B inhibitor-like protein 1; ikappaBL; I-kappa-B-like protein; inhibitor of kappa B-like protein;
MUC13
mucin 13, cell surface associated
MUC13; mucin 13, cell surface associated; down regulated in colon cancer 1 , DRCC1, mucin 13, epithelial transmembrane; mucin-13; down-regulated in colon cancer 1; mucin 13, epithelial transmembrane; DRCC1; MUC-13; FLJ20063;
MUC15
mucin 15, cell surface associated
MUC15; mucin 15, cell surface associated; mucin-15; PAS3; MUC-15; PASIII;
MUC20
mucin 20, cell surface associated
MUC20; mucin 20, cell surface associated; mucin-20; FLJ14408; KIAA1359; MUC 20; MUC-20; MUC20_HUMAN; Mucin 20; Transmembrane mucin MUC20S;
MUC3B
mucin 3B, cell surface associated
MUC3B; mucin 3B, cell surface associated; mucin 3B; mucin-3B; Intestinal mucin 3B; MUC 3A; MUC 3B; MUC3; MUC3A; MUC-3B; intestinal mucin-3B; intestinal mucin MUC3B;
MS4A3
membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific)
MS4A3; membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific); CD20L; membrane-spanning 4-domains subfamily A member 3; HTM4; CD20 antigen homolog; CD20 antigen like; CD20 antigen like protein; hematopoietic cell 4 transmembrane protein; Hematopoietic-specific transmembrane protein 4; IgE receptor beta subunit; OTTHUMP00000235850; OTTHUMP00000235851; OTTHUMP00000235853; IgE receptor beta chain; CD20 antigen-like protein;
NFATC4
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
NFATC4; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4; NFAT3; NF-AT3; NF-ATC4; nuclear factor of activated T-cells, cytoplasmic 4; T-cell transcription factor NFAT3;
KLRC2
killer cell lectin-like receptor subfamily C, member 2
KLRC2; killer cell lectin-like receptor subfamily C, member 2; NKG2-C type II integral membrane protein; CD159c; NKG2 C; NK cell receptor C; NKG2-C-activating NK receptor; CD159 antigen-like family member C; NKG2C; NKG2-C; MGC138244;
PARD6A
par-6 family cell polarity regulator alpha
PARD6A; par-6 family cell polarity regulator alpha; PAR6; PAR6C; TAX40; PAR-6A; TIP-40; PAR6alpha; partitioning defective 6 homolog alpha; PAR-6 alpha; Tax-interacting protein 40; tax interaction protein 40; partitioning-defective protein 6; partitioning defective-6 homolog alpha; par-6 partitioning defective 6 homolog alpha;
SIGMAR1
sigma non-opioid intracellular receptor 1
SIGMAR1; sigma non-opioid intracellular receptor 1; opioid receptor, sigma 1 , OPRS1; SR BP1; SR-BP; SIG-1R; sigma1R; hSigmaR1; SR31747 binding protein 1; sigma 1-type opioid receptor; aging-associated gene 8 protein; SRBP; ALS16; OPRS1; SR-BP1; MGC3851;
SDF2L1
stromal cell-derived factor 2-like 1
SDF2L1; stromal cell-derived factor 2-like 1; stromal cell-derived factor 2-like protein 1; AP000553.C22.4; dihydropyrimidinase like 2; OTTHUMT00000075032; PWP1 interacting protein 8; SDF2-like 1; SDF2-like protein 1; PWP1-interacting protein 8; dihydropy;
MZB1
marginal zone B and B1 cell-specific protein
MZB1; marginal zone B and B1 cell-specific protein; plasma cell-induced resident endoplasmic reticulum protein; FLJ32987; HSPC190; MGC29506; PACAP; pERp1; Plasma cell-induced ER protein 1; Plasma cell-induced resident ER protein; Proapoptotic caspase adapter protein; caspase-2 binding protein; proapoptotic caspase adaptor protein;
SCAI
suppressor of cancer cell invasion
SCAI; suppressor of cancer cell invasion; C9orf126, chromosome 9 open reading frame 126; protein SCAI; FLJ36664; NET40; C9orf126; FLJ11758; MGC120525; MGC120526; MGC120528; SCAI_HUMAN; Suppressor of cancer cell invasion protein;
SMAGP
small cell adhesion glycoprotein
SMAGP; small cell adhesion glycoprotein; hSMAGP; MGC149453; MGC149454; small trans membrane and glycosylated protein; small cell transmembrane and glycosylated protein; small transmembrane and glycosylated protein; small trans-membrane and glycosylated protein;
SDK1
sidekick cell adhesion molecule 1
SDK1; sidekick cell adhesion molecule 1; sidekick homolog 1 (chicken) , sidekick homolog 1, cell adhesion molecule (chicken); protein sidekick-1; FLJ31425; sidekick homolog 1, cell adhesion molecule;
SART1
squamous cell carcinoma antigen recognized
SART1; squamous cell carcinoma antigen recognized; squamous cell carcinoma antigen recognised by T cells; U4/U6.U5 tri-snRNP-associated protein 1; Ara1; small nuclear ribonucleoprotein 110kDa (U4/U6.U5); SNRNP110; Snu66; Ara 1; HOMS 1; HOMS1; hSART 1; hSART1; hSnu 66; hSnu66; IgE autoantigen; SART 1; SART1 259; SART1(259) protein; SART1(800) protein; SART1259; Snu 66; Squamous cell carcinoma antigen recognized by T cells 1; U4/U6.U5 tri snRNP associated 110 kDa protein; U4/U6.U5 tri snRNP associated protein 1; SART-1; hSART-1; SNU66 homolog; U4/U6.U5 tri-snRNP-associated 110 kDa protein;
SART3
squamous cell carcinoma antigen recognized
SART3; squamous cell carcinoma antigen recognized; squamous cell carcinoma antigen recognised by T cells 3; squamous cell carcinoma antigen recognized by T-cells 3; KIAA0156; RP11 13G14; hSART 3; p110(nrb); RP11-13G14; Tat interacting protein of 110 kDa; TIP110; SART-3; hSART-3; tat-interacting protein of 110 kDa; P100; p110; DSAP1;
TAGAP
T-cell activation RhoGTPase activating protein
TAGAP; T-cell activation RhoGTPase activating protein; T cell activation GTPase activating protein; T-cell activation Rho GTPase-activating protein; ARHGAP47; FLJ32631; IDDM21; FLJ39771; MGC133247; MGC27381; MGC31468; TAGAP1; 2610315E15Rik; FKSG15; T cell activation Rho GTPase activating protein; T-cell activation GTPase-activating protein; TAGAP_HUMAN;
TAL1
T-cell acute lymphocytic leukemia 1
TAL1; T-cell acute lymphocytic leukemia 1; TCL5; T-cell acute lymphocytic leukemia protein 1; bHLHa17; SCL; Class A basic helix-loop-helix protein 17; OTTHUMP00000009563; OTTHUMP00000009564; Stem cell protein; T cell acute lymphocytic leukemia 1; T cell acute lymphocytic leukemia 1 protein; T cell leukemia/lymphoma 5 protein; T-cell leukemia/lymphoma protein 5; Tal 1; Tal 1 product; TAL 1 protein; TAL-1; TAL1_HUMAN; TCL 5; tal-1 product;
TIAM1
T-cell lymphoma invasion and metastasis 1
TIAM1; T-cell lymphoma invasion and metastasis 1; T-lymphoma invasion and metastasis-inducing protein 1; T cell lymphoma invasion and metastasis 1; T lymphoma invasion and metastasis inducing TIAM1 protein; TIAM-1; TIAM1_HUMAN; OTTHUMP00000107263; human T-lymphoma invasion and metastasis inducing TIAM1 protein;
TRCG1
taste receptor cell gene 1
TRCG1; taste receptor cell gene 1; taste receptor cell protein 1; Taste receptor protein 1;
URGCP
upregulator of cell proliferation
URGCP; upregulator of cell proliferation; up-regulated gene 4; DKFZp666G166; DKFZp686O0457; FLJ20654; KIAA1507; up regulated gene 4; URG4; HBV X protein up-regulated gene 4 protein; HBV X protein upregulated gene 4 protein; HBxAg up-regulated gene 4 protein; HBxAg upregulated gene 4 protein; Up-regulator of cell proliferation; Upregulated gene 4; URGCP_HUMAN;
UTF1
undifferentiated embryonic cell transcription factor 1
UTF1; undifferentiated embryonic cell transcription factor 1;
UBL7
ubiquitin-like 7 (bone marrow stromal cell-derived)
UBL7; ubiquitin-like 7 (bone marrow stromal cell-derived); ubiquitin-like protein 7; ubiquitin like protein SB132; BMSC UbP; bone marrow stromal cell derived ubiquitin like; MGC14421; 2300004C15Rik; BMSC-UbP; BMSCUBP; Bone marrow stromal cell derived ubiquitin like protein; Bone marrow stromal cell ubiquitin-like protein; MGC94284; TCBA1; Ubiquitin like 7 (bone marrow stromal cell derived); Ubiquitin like 7; Ubiquitin-like protein SB132; UBL7_HUMAN;
CADM4
cell adhesion molecule 4
CADM4; cell adhesion molecule 4; IGSF4C, immunoglobulin superfamily, member 4C; Necl 4; nectin like 4; SynCAM4; TSLL2; TSLC1-like 2; nectin-like 4; TSLC1-like protein 2; nectin-like protein 4; immunoglobulin superfamily member 4C; immunoglobulin superfam;
CADM2
cell adhesion molecule 2
CADM2; cell adhesion molecule 2; IGSF4D, immunoglobulin superfamily, member 4D; Necl 3; NECL3; nectin like 3; SynCAM2; nectin-like 3; nectin-like protein 3; immunoglobulin superfamily member 4D; immunoglobulin superfamily, member 4D; IGSF4D; Necl-3; synC;
CEACAM16
carcinoembryonic antigen-related cell adhesion molecule 16
CEACAM16; carcinoembryonic antigen-related cell adhesion molecule 16; Carcinoembryonic antigen like 2; Carcinoembryonic antigen like 2 protein; Carcinoembryonic antigen related cell adhesion molecule 16; CEAL2; carcinoembryonic antigen-like 2; carcinoembryonic antigen like-2 protein;
CREG2
cellular repressor of E1A-stimulated genes 2
CREG2; cellular repressor of E1A-stimulated genes 2; protein CREG2;
DSCAM
Down syndrome cell adhesion molecule
DSCAM; Down syndrome cell adhesion molecule; Down syndrome cell adhesion molecule homolog; 4932410A21Rik;
ELFN2
extracellular leucine-rich repeat and fibronectin type III domain containing 2
ELFN2; extracellular leucine-rich repeat and fibronectin type III domain containing 2; extracellular leucine rich repeat and fibronectin type III containing 2 , extracellular leucine rich repeat and fibronectin type III domain containing 2 , leucine ric;
Icam5
intercellular adhesion molecule 5, telencephalin
ICAM5; intercellular adhesion molecule 5, telencephalin; TLCN; intercellular adhesion molecule 5; telencephalin; TLN; ICAM-5; CD50; Icam3; ICAM-3; MGC130520; intercellular adhesion molecule 3;
KIR2DL5A
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A
KIR2DL5A; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A; CD158F; KIR2DL5; KIR2DL5.1;
KIR3DS1
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
KIR3DS1;killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1;killer cell immunoglobulin-like receptor 3DS1;nkat10;NKAT-10;killer Ig receptor;MHC class I NK cell receptor;natural killer-associated transcript 10;killer cell immunoglobulin-like receptor KIR3DS1;KIR-G1;NKAT10;CD158E2;KIR-123FM;MGC119726;MGC119728;MGC125316;
MEMO1
mediator of cell motility 1
MEMO1;mediator of cell motility 1;14014;ENSG00000162959;MEMO;C2orf4;CGI-27;NS5ATP7;2p22-p21;FLJ25031, DKFZp434I0135;protein MEMO1;protein MEMO1;memo-1;C21orf19-like protein;HCV NS5A-transactivated protein 7;mediator of ErbB2-driven cell motility 1;hepatitis C virus NS5A-transactivated protein 7;
Mcpt8
mast cell protease 8
MCPT8;mast cell protease 8;ENSMUSG00000022157;MMCP-8;BB139338;14 C3;14 20.0 cM;mast cell protease 8;mast cell protease 8;
Klra7
killer cell lectin-like receptor, subfamily A, member 7
KLRA7;killer cell lectin-like receptor, subfamily A, member 7;ENSMUSG00000067599;LGL-1;Ly49g;Ly49g1;Ly49g2;Ly49G.4;Ly-49G.1;Ly-49G.2;Ly-49G.3;6 F3;6 62.7 cM;MGC123448, MGC161317;killer cell lectin-like receptor 7;killer cell lectin-like receptor 7;ly-49g;lymphocyte antigen 49g;T-cell surface glycoprotein Ly-49G;
Treml4
triggering receptor expressed on myeloid cells-like 4
TREML4;triggering receptor expressed on myeloid cells-like 4;ENSMUSG00000051682;TLT4;IDCP1;Treml3;BB137214;5031403H21Rik;17 C;17;triggering receptor expressed on myeloid cells-like 4;triggering receptor expressed on myeloid cells-like 4;IG-like domain containing protein IDCP1c;triggering receptor expressed on myeloid cells-like 3;triggering receptor expressed on myeloid cells-like 3b;
Klra4
killer cell lectin-like receptor, subfamily A, member 4
KLRA4;killer cell lectin-like receptor, subfamily A, member 4;ENSMUSG00000079852;Chok;Ly49d;Klra32;Ly-49d;ly49r<129>6 F3;6 62.68 cM;killer cell lectin-like receptor 4;killer cell lectin-like receptor 4;lymphocyte antigen 49d;T-cell surface glycoprotein Ly-49D;killer cell lectin-like receptor subfamily A member 32;
Klra8
killer cell lectin-like receptor, subfamily A, member 8
KLRA8;killer cell lectin-like receptor, subfamily A, member 8;ENSMUSG00000089727;Cmv1;Cmv-1;Ly49h;Ly49u<129>6 F3;6 62.69 cM;killer cell lectin-like receptor 8;killer cell lectin-like receptor 8;ly-49h;lymphocyte antigen 49h;cytomegalovirus resistance 1;T-cell surface glycoprotein Ly-49H;
Klra5
killer cell lectin-like receptor, subfamily A, member 5
KLRA5;killer cell lectin-like receptor, subfamily A, member 5;ENSMUSG00000030173;Ly49e;6 F3;6 62.62 cM;killer cell lectin-like receptor 5;killer cell lectin-like receptor 5;ly-49e;Ly49E receptor;lymphocyte antigen 49e;class I MHC receptor KLRA5;T-cell surface glycoprotein Ly-49E;
SDK2
sidekick cell adhesion molecule 2
SDK2;sidekick cell adhesion molecule 2;19308;ENSG00000069188;17q25.1;FLJ10832, KIAA1514;protein sidekick-2;protein sidekick-2;sidekick homolog 2;
GMCL1
germ cell-less, spermatogenesis associated 1
GMCL1;germ cell-less, spermatogenesis associated 1;23843;ENSG00000087338;GCL;GCL1;BTBD13;2p13.3;germ cell-less protein-like 1;germ cell-less protein-like 1;germ cell-less homolog 1;
KLRG2
killer cell lectin-like receptor subfamily G, member 2
KLRG2;killer cell lectin-like receptor subfamily G, member 2;24778;ENSG00000188883;CLEC15B;7q34;FLJ44186, MGC131846;killer cell lectin-like receptor subfamily G member 2;killer cell lectin-like receptor subfamily G member 2;C-type lectin domain family 15 member B;C-type lectin domain family 15, member B;
METRNL
meteorin, glial cell differentiation regulator-like
METRNL;meteorin, glial cell differentiation regulator-like;27584;ENSG00000176845;17q25.3;MGC99788;meteorin-like protein;meteorin-like protein;
NFKBID
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta [ Homo sapiens
NFKBID;nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta;15671;ENSG00000167604;TA-NFKBH;IkappaBNS;19q13.12;MGC11314, MGC149503;NF-kappa-B inhibitor delta;NF-kappa-B inhibitor delta;ikB-delta;ikappaBdelta;I-kappa-B-delta;T-cell activation NFKB-like protein;
TCTA
T-cell leukemia translocation altered
TCTA;T-cell leukemia translocation altered;11692;ENSG00000145022;3p21;T-cell leukemia translocation-altered gene protein;T-cell leukemia translocation-altered gene protein;T-cell leukemia translocation-associated gene protein;
TLX2
T-cell leukemia homeobox 2
TLX2;T-cell leukemia homeobox 2;5057;ENSG00000115297;NCX;HOX11L1;2p13.1;T-cell leukemia homeobox protein 2;T-cell leukemia homeobox protein 2;homeo box 11-like 1;homeobox protein Hox-11L1;neural crest homeobox protein;
CDC40
cell division cycle 40 homolog (S. cerevisiae)
CDC40;cell division cycle 40 homolog (S. cerevisiae);17350;ENSG00000168438;EHB3;PRP17;PRPF17;6q21;FLJ10564, MGC102802;pre-mRNA-processing factor 17;pre-mRNA-processing factor 17;hPRP17;PRP17 homolog;EH-binding protein 3;pre-mRNA splicing factor 17;
Cma2
chymase 2, mast cell
CMA2;chymase 2, mast cell;ENSMUSG00000068289;Mcp10;14 C3;14;mast cell protease 10;mast cell protease 10;
Tcl1
T cell lymphoma breakpoint 1
TCL1;T cell lymphoma breakpoint 1;ENSMUSG00000041359;Tcl1a;12 E;12 52.0 cM;T-cell leukemia/lymphoma protein 1A;T-cell leukemia/lymphoma protein 1A;TCL-1;oncogene TCL1;oncogene TCL-1;protein p14 TCL1;T-cell lymphoma breakpoint 1;
FDCSP
follicular dendritic cell secreted protein
UNQ733/PRO1419; C4orf7; FDC-SP; FDCSP; follicular dendritic cell secreted protein;
RGCC
regulator of cell cycle
RGCC;regulator of cell cycle;20369;ENSG00000102760;RGC32;RGC-32;C13orf15;bA157L14.2;13q14.11;KIAA0564, MGC87338;regulator of cell cycle RGCC;regulator of cell cycle RGCC;response gene to complement 32 protein;
ECT2L
epithelial cell transforming sequence 2 oncogene-like
ECT2L;epithelial cell transforming sequence 2 oncogene-like;21118;ENSG00000203734;LFDH;FBXO49;C6orf91;ARHGEF32;dJ509I19.2;dJ509I19.3;dJ509I19.5;6q24.1;epithelial cell-transforming sequence 2 oncogene-like;epithelial cell-transforming sequence 2 oncogene-like;ECT2-like;F-box protein 49;putative guanine nucleotide exchange factor LFDH;lung specific F-box and DH domain containing protein;lung-specific F-box and DH domain-containing protein;
CDCA7
cell division cycle associated 7
CDCA7;cell division cycle associated 7;14628;ENSG00000144354;JPO1;2q31;FLJ14722, FLJ14736, MGC34109;cell division cycle-associated protein 7;cell division cycle-associated protein 7;c-Myc target JPO1;cell division cycle associated protein 7;
CWF19L1
CWF19-like 1, cell cycle control (S. pombe)
CWF19L1;CWF19-like 1, cell cycle control (S. pombe);25613;ENSG00000095485;RP11-316M21.3;10q24.31;FLJ10998;CWF19-like protein 1;CWF19-like protein 1;
ECM2
extracellular matrix protein 2, female organ and adipocyte specific
ECM2;extracellular matrix protein 2, female organ and adipocyte specific;3154;ENSG00000106823;9q22.3;MGC126355, MGC126356;extracellular matrix protein 2;extracellular matrix protein 2;matrix glycoprotein SC1/ECM2;
BOD1L1
biorientation of chromosomes in cell division 1-like 1
BOD1L1;biorientation of chromosomes in cell division 1-like 1;31792;ENSG00000038219;BOD1L;FAM44A;4p16.1;FLJ33215, KIAA1327;biorientation of chromosomes in cell division protein 1-like 1;biorientation of chromosomes in cell division protein 1-like 1;family with sequence similarity 44, member A;
BOD1L
biorientation of chromosomes in cell division 1-like
FAM44A; AI853319; mKIAA1327; A230054D04Rik;
Ceacam12
carcinoembryonic antigen-related cell adhesion molecule 12
Ceacam12C1; Ceacam12C3; Ceacam12-C1; Ceacam12-C3; 1600031J20Rik;
Ceacam14
carcinoembryonic antigen-related cell adhesion molecule 14
AV033953; 1600021E03Rik; 1600025E09Rik;
DSCAML1
Down syndrome cell adhesion molecule-like 1
BB239540; mKIAA1132; 4921507G06Rik; 4930435C18Rik;
ELFN1
extracellular leucine-rich repeat and fibronectin type III domain containing 1
Ppp1r28; AI197272; A930017N06Rik;
Gcap14
granule cell antiserum positive 14
Fam190b; AI035535; AW108503; 1700012P13Rik; 2900054P12Rik;
KIR3DL3
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3
KIR44; KIRC1; CD158Z; KIR3DL7;
Klra12
killer cell lectin-like receptor subfamily A, member 12
Ly49L; Ly49l1; Ly49l2; Ly49l3; Ly49l4; Ly49p/d;
Klra14
killer cell lectin-like receptor subfamily A, member 14
Ly49N; Klra29; Klra31; Gm15858; EG654449; OTTMUSG00000026959;
Klrb1f
killer cell lectin-like receptor subfamily B member 1F
Nkrp1f; Nkr-p1f; Nkrp1-f; A630024B12Rik;
RGD1565672
Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa
RGD1565672;
PPDPF
PPDPF pancreatic progenitor cell differentiation and proliferation factor homolog (zebrafish) [ Homo sapiens ]
pancreatic progenitor cell differentiation and proliferation factor homolog(zebrafish); Exocrine differentiation and proliferation factor; C20orf149; hromosome 20 open reading frame 149; dJ697K14.9; pancreatic progenitor cell differentiation and proliferation factor; exdpf; EXPDF;
CD66a
carcinoembryonic antigen-related cell adhesion molecule 1
Bgp; Cc1; Hv2; Bgp1; Cea1; Cea7; Hv-2; MHVR; bb-1; C-CAM; CD66a; Cea-1; Cea-7; MHVR1; Mhv-1; mCEA1; mmCGM1; mmCGM2; mmCGM1a;
CD66c
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
NCA; CEAL; CD66c;
vnc
vnc variable nurse cells [ Drosophila melanogaster (fruit fly) ]
ard1; CG11989; dArd1; DmAAF50178; Dmel\CG11989; Dromel_CG11989_FBtr0076348_ard1_mORF; l(3)67BDk; vnc Ard1; CG11989-PA; CG11989-PB; CG11989-PC; CG11989-PD; CG11989-PE; arrest defective 1; arrest defective1; lethal (3) 67BDk; variable nurse cell; variable nurse cells; vnc-PA; vnc-PB; vnc-PC; vnc-PD; vnc-PE;
CTAGE1
CTAGE1 cutaneous T-cell lymphoma-associated antigen 1 [ Homo sapiens (human) ]
Cancer/testis antigen 21.2; Cancer/testis antigen family 21 member 1; Cancer/testis antigen family 21 member 2; CT21.2; CTAGE 1; CTAGE 2; CTAGE; CTAGE1; CTGE2_HUMAN; Cutaneous T cell lymphoma associated antigen 1; Cutaneous T cell lymphoma associated antigen 2; Protein cTAGE-2;
GMCL1P1
MCL1P1 germ cell-less, spermatogenesis associated 1 pseudogene 1 [ Homo sapiens (human) ]
germ cell-less, spermatogenesis associated 1 pseudogene 1; GCL; GMCL1L; GMCL2; germ cell-less homolog 1 (Drosophila) pseudogene 1; germ cell-less homolog 1 (Drosophila)-like;
Baculovirus-Insect Cell Expression
At Creative BioMart, our team of experts have developed baculovirus-insect cell expression platform for virus production and recombinant protein manufacture in various scales. The ability of Creative BioMart's baculovirus-insect cell system to express proteins with complex post-translational modific...
Cell Line Development and Membrane Preparation
Creative BioMart uses a proprietary technology to enable expression of membrane proteins in mammalian cells at over a million molecules per cell surface. High expressing cells can be developed into single cell clones and be used as uniq...
cGMP Cell-Based Potency Assays
Cells are living entities, representing biological systems that possess many of the important in vivo characteristics that make them useful for measuring biological activity. The reducing cost and short time frames make cell-based potency assays possess a number of advantages over animal models. C...
Cell-Free Based Protein Analytical
Cell-free system is an in vitro tool widely used to study biological reactions that happen within cells while reducing the complex interactions found in a whole cell. As a leader specialized in protein analysis, Creative BioMart has acquired long experience and expert knowledge in cell-free system....
Cell-Free In Vitro Protein Expression
As a leading supplier for reagents in the biotechnology field, we understand the importance of convenient and easy-to-use systems for the expression of proteins including large proteins and membrane proteins, which are challenging for traditional expression systems. Creative BioMart has developed ce...
Stable Cell Line Services
Stable cell line service at Creative BioMart covers all your needs in the aspects of protein production and assay development. Not only have we developed cell lines stable at expression level, but also established stable cell lines ready for assay development. Creative BioMart stable cell line platf...
Host Cell Protein Mitigation
Recombinant protein drug products are often contaminated with proteins from the host cell system from which they were derived. Called host cell proteins (HCP), these contaminating proteins often co-purify along with the therapeutic protein from its growth media. There are thousands of HCP variants, ...
Human Synthetic Proteins Produced in Mammalian Cell Lines
Creative BioMart has developed a novel approach to both increase biological activities and reduce production costs of human synthetic proteins in mammalian cell lines. The stable transfection of particular cell lines with human sialyltransferases (a set of enzymes involves in protein glycosylation) ...
Human Cell Line Activation Test (h-CLAT)
Chemicals can cause the immunological sensitization of skin tissue. Upon repeated exposure, it can lead to allergic reaction of the skin (Allergic Contact Dermatitis, ACD). Because of increasing social concern about animal welfare and the use of animals in testing, many alternative, non-animal tests...
Cell-free Display Platform
Many types of cell-free approaches have been developed for directed evolution in which the presence of cells is not required. For example, ribosome display, mRNA display, aptamers, in vitro compartmentalization (IVC), cis-activity based (CIS) display and covalent antibody display (CAD) are, among ot...
Special Cell-based Display Platform
Besides commonly used hosts, such as E. coli, yeast and phage, there are other cells that can also be used for protein display, although not widely employed. Gram-positive bacteria display method, for example, is playing a special role in directed evolution. Because of the rigid structure of their c...
Intracellular Cytokine Detection and Activity Assay
Cytokines are a class of widely biologically active small molecule proteins which are synthesized and secreted upon stimulation by immune cells (such as monocytes, macrophages, T cells, B cells, NK cells, etc.) and certain non-immune cells (endothelial cells, epidermal cells, fibroblasts, etc.). Cyt...
Detergent Micelle Platform
Proteins are inserted in lipid bilayers through hydrophobic interactions between lipid tails and hydrophobic protein structural domains. These integral membrane proteins are insoluble in aqueous solution and are aggregated. However, they can be soluble in descaling agents, which form micelles simila...
GMP Stable Cell Line Development Platform
The construction of efficient and stable cell lines is crucial for developing CMC for macromolecule drugs and is also a critical factor in obtaining high-quality proteins and antibodies. Creative Biomart has a complete GMP cell line construction platform and provides comprehensive and professional G...
NK Cells & Brain Tumors: Immune cells attack Therapeutic Viruses
We have natural guard system inside us, such as our immune system, which on one hand protect us, while on other hand hinder us too according to a research of Ohio State University Comprehensive Cancer Center. Their findings were published in the journal of Nature Medicine. They did some researches ...
Nature Method: How to Effectively and Safely Produce Stem Cell
Stem cells are biological cells found in all multicellular organisms, that can divide through mitosis and differentiate into diverse specialized cell types or can self renew to produce more stem cells. In mammals, there are two broad types of stem cells: embryonic stem cells (ESCs) that are isolat...
A New Feature of Cell Division: the Interactions among Chromosome, Telomere and Cell Division
The yellow part refers to telomeres, the protective caps on the ends of chromosomes, moving to the outer edge of a cell's nucleus (the blue part) The constant new replacing old and impaired contributes to our life maintenance and growth. You may feel at sea by reading the first sentence, well...
Food Poison: Cellular Toxicity Caused By Nhe Was First Revealed in a Doctoral Thesis
Recently a doctoral research revealed a protein structure of how Bacillus cereus causes toxin. The author is Danh Phung, he found the crystalline structure of NheA. Phung's study is the first to show that the Nhe proteins form structures resembling pores. We know that food poisoning caused byBaci...
Cell: A Promising Trend That Avoids Foreign Rejection and Replaces Damaged Neurons on self
This is a confocal micrograph of a primary human fibroblast cell grown in culture stained blue for actin, a highly abundant protein that makes up the cytoskeleton of cells. Mitochondria are shown in green. According to some statistics, it is estimated that 25% Americans will suffer from a neurode...
Cell Biology: The Importance of PEFs in Cell Mitosis
The picture shows the expression of the chromokinesin NOD (red) stabilizes aberrant interactions between kinetochores and spindle microtubules (green). Cell division helps to maintain the even distribution genome of two daughter cells in which every chromosome need to properly interact wi...
Protein Bax: Reveal One Potential Mechanism of Cell Death
The left picture shows the main researchers of this finding; the right picture shows the visualization of the molecular changes in protein Bax Cell death, or apoptosis, is an important factor in controlling the number of cells in the body. Proper cell numbers ensure our health condition; over...
Cell: the “Protein backbone” of the Yeast Telosome
A model of the Rap1-Rif1-Rif2 Assembly at Telomeres Researchers have made a molecular, biochemical, and functional dissection on the protein backbone at the core of the yeast telosome. Repeated sequences form the genome as the sequence motif links sequence motif as well as binds proteins. Thes...
The Important Roles of MBNL Proteins in the Pluripotency of Stem Cells
Induced pluripotent stem cells are a vital research direction for the future academic and medical application. In past studies, scientists have paid much attention on the part of transcription, chromatin and non-coding RNA regulators of the pluripotency of embryonic stem (ES) cells. Alternative ...
Scientists Identified the Role of Osteopontin for Mesenchymal Stem Cells
As a kind of stem cells , mesenchymal stem cells (MSCs) play an important role in the repair of damaged tissue due to its differentiation potential, and it has broad application prospects in the field of regenerative medicine. In recent years, many studies agree ...
Find Excellent Protein Labeling & Conjugation Solutions at Creative BioMart
Labeled proteins are important reagents in numerous biological applications such as assays, purifications, protein arrays, localization studies, flow cytometry, clinical imaging and much more. With labeled proteins, researchers are allowed to study specific molecular interactions with high sensiti...
Scientists Revealed the Mystery of Cell Proliferation
According to scientific materials, before cells divide, they create so much genetic material that it must be twined onto spools, proteins called histones, before the two new cells can split apart. Moreover, there histones must multiply at the same moment that cell doubles its DNA. If not, the new DN...
Cell: Scientists Found another Role of Enzyme Superoxide Dismutase
Since 1960s, the initial discovery of Superoxide dismutase (SOD1), an enzyme that was believed having solo role in protecting living cells against damage from free radicals by scientists. The enzyme is present in all living cells, from the most ancient bacteria to every cell in the human body. ...
Besides Cell Lines Culture, Lipid Storage etc., a New Application of Gene Plin2 was Found
Nowadays weight losing is very popular among women, even men. They adopt diet, exercise, medicine control etc. to achieve the result. But every coin has two sides and you need to pay something. On Lipid Research, a two-year study revealed an exciting finding that deleting a specific gene in m...
Cell: The Role of EDRA Gene in Evolution
The picture shows the mice carrying a human version of the EDAR gene have footpads with more sweat glands (blue tubes). About 30,000 years ago, China was a warm and humid place. Thus people living here usually have more sweat glands to cool self temperature. But why and how is unclear to peop...
Induce Some Cells into other Cells without via Stem Cells
Reprogramme skin and glia cells into nerve cells Re-programmed nerve cell When I mentioned about turning one cell type into other cell type, will you think about stem cells or pluripotentstem cells which can oriented induce some type to...
PNAS: A New Study Revealed the Spread Path of Cell Transmission
Microscope image of Nerve cells: Spreading of protein particles between cells. According to a newly published lab study in the Proceedings of the National Academy of Sciences(PNAS), some protein particles can multiply and spread cell transmission. This finding would be meaningful for neurosci...
CD44, CD47 and MET Have been Found Related to Initiation of Metastatic Cancer Cells
Circulating tumor cells (CTCs) are now treated as a biomarker for prognosis and people think the CTCs are connected to cancer metastasis. But there is no clear clue to clarify how CTCs affect patients. Some scientists thought only few CTCs will form secondary tumor in different organs as the metast...
Science: Studies Revealed a New Innate Immunity Sensor of Enzyme and Cell Signaling Pathway
Scientists have known the immune-boosting response of DNA for a long time, but the specific mechanism of the underlying response is unknown. The studies solved the longstanding puzzle by means of a special biochemical approach. The approach is quantitative mass spectrometry which adopts a modern ...
Cell: Researchers Found a Novel Rule of Membrane Proteins
Like the teeth of a zipper, the charged amino acids (as the red and blue color show) form connections between protein segments and thus form pores in the cell membrane. Membrane proteins, attached to or associated with themembraneof acellor anorganelle, perform a variety of functions vita...
The 2nd Annual Cell Line Development and Engineering in Asia
When March 4th, 2013, to March 6th, 2013 Where Grand Hvatt Shanghai, China Introduction This conference is organized by IBC Asia (s) Pte Ltd and be held al...
Partnership between EMD Milipore and Systemic on Control Markers for Stem Cell
On the second annual Stem Cell Meeting on the Mesa, EMD Millipore and Systemic Ltd. declaimed becoming partners to identify control markers for stem cell production. EMD Millipore, the life science division of Merck KGaA of Germany. It is expertise of stem cells. Systemic Ltd, a leading provider of...
The 2nd Anticancer Agents Congress: Targeting Cancer Stem Cell
When November 21 to 24th 2013 Where Belek, Antalya, Turkey (the congress hotel will be announced soon) Introduction Sponsored by EACR, the meeting aims to bring all kinds of anti-cancer agents researchers together and discuss recent achievements in the field of basic research on ...
GTC 2013, Stem Cell Commercialization & Partnering conference
Introduction GTC's Stem Cell Commercialization Partnering conference, part of the 10th Stem Cell Summit, will be held on in Boston. This conference will present information regarding cutting-edge developments in all areas of stem cell research including Stem Cell, Induced Pluripotent Stem Ce...
The 2nd Annual Cell Culture World Congress USA in Boston
Introduction The 2nd annual Cell Culture World Congress USA is North America's leading conference focused on the optimization and development of cell culture bioproduction. This is a chance for biopharma, biotechs, biomanufacturing and process experts come to debate advances in cell culture optim...
Cell culture
Cell culture introduction Most of animal cell lines grow on substrate as monolayer only a single thickness. In this case, once the all the surface of substrate is covered by cells, the cells stop growing and then following by differentiation or death. So its necessary to subculture cells regular...
Protocol of Stable Cell Line Generation
Background The generation of stably-transfected cell lines is critical for a wide range of applications. It is applied to the production of recombinant proteins, gene function studies, as well as drug discovery assays. Stable expression of target gene in cell lines overcomes the low transfection ef...
Protocol of Preparation of the Subcellular Organelle Protein Samples
In organism, the compartmentalization of cell makes different subcellular organelles have their own protein system, and many functions of protein can be realized through subcellular organelles. In addition, organelles have dynamic structures, such as endoplasmic reticulum, nucleus and Golgi apparatu...
Guide of Protein Subcellular Co-localization
Green fluorescence protein (GFP) has become one of the most interesting proteins in protein science research due to its unique physical and chemical properties. Because GFP has the ability to emit fluorescence in vivo, it can be used to detect and trace the expression level, location and protein int...
Guide of Analysis of Transient Cell Interaction
In 1993, Swiss scientist Rossi and others created an agrobacterium-mediated gene transient expression system. They induced agrobacterium with recombinant plasmid to infiltrate plant leaves and then plant cells through vacuum. Then people injected the leaves of living plants through needle tubes to d...
